Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-128-3p A2M 1.64 0 -2.68 0 miRNAWalker2 validate -0.74 0 NA
2 hsa-miR-374b-5p ABAT 0.07 0.72267 -0.34 0.43051 MirTarget; miRNATAP -0.33 0.00396 NA
3 hsa-miR-128-3p ABCA1 1.64 0 -0.71 0.00276 MirTarget -0.19 0.00014 NA
4 hsa-miR-361-5p ABCA1 0.97 0 -0.71 0.00276 miRanda; mirMAP -0.32 0 NA
5 hsa-miR-374a-5p ABCA1 0.48 0.0043 -0.71 0.00276 mirMAP -0.15 0.03261 NA
6 hsa-miR-374b-5p ABCA5 0.07 0.72267 -0.2 0.46525 MirTarget; mirMAP -0.17 0.02271 NA
7 hsa-miR-450b-5p ABCA5 1.69 0 -0.2 0.46525 mirMAP -0.15 0.00278 NA
8 hsa-miR-361-5p ABCA8 0.97 0 -5.33 0 miRanda -0.7 0.00034 NA
9 hsa-miR-299-5p ABCC4 -0.27 0.38683 -1.54 1.0E-5 MirTarget -0.12 0.02929 NA
10 hsa-miR-450b-5p ABCC4 1.69 0 -1.54 1.0E-5 mirMAP -0.15 0.0187 NA
11 hsa-miR-142-3p ABCC5 2.75 0 0.08 0.78106 miRanda -0.11 0.00182 NA
12 hsa-miR-339-5p ABCC9 2.69 0 -2.76 0 miRanda -0.4 0 NA
13 hsa-miR-374a-5p ABCC9 0.48 0.0043 -2.76 0 mirMAP -0.38 0.00152 NA
14 hsa-miR-450b-5p ABCC9 1.69 0 -2.76 0 mirMAP -0.22 0.00333 NA
15 hsa-miR-944 ABCC9 2.91 0 -2.76 0 mirMAP -0.3 0 NA
16 hsa-miR-361-5p ABCD2 0.97 0 -3.08 0 miRanda -1.28 0 NA
17 hsa-miR-452-5p ABCD2 1.37 0.00171 -3.08 0 mirMAP -0.22 4.0E-5 NA
18 hsa-miR-944 ABCD2 2.91 0 -3.08 0 mirMAP -0.31 0 NA
19 hsa-miR-23b-3p ABCF1 -0.25 0.1502 0.13 0.23372 miRNAWalker2 validate -0.12 0.00018 NA
20 hsa-miR-944 ABCG2 2.91 0 -1.34 0.00067 mirMAP -0.13 7.0E-5 NA
21 hsa-miR-143-3p ABHD14A -2.58 0 0.12 0.60515 MirTarget -0.15 0 NA
22 hsa-miR-339-5p ABHD2 2.69 0 -0.37 0.12248 PITA -0.1 0.00324 NA
23 hsa-miR-23a-3p ABI2 1 0 -0.65 0 mirMAP -0.11 0.00152 NA
24 hsa-miR-374a-5p ABI3BP 0.48 0.0043 -4.28 0 mirMAP -0.31 0.0397 NA
25 hsa-miR-128-3p ABL1 1.64 0 -1.32 0 MirTarget -0.21 0 NA
26 hsa-miR-361-5p ABL1 0.97 0 -1.32 0 miRanda -0.32 0 NA
27 hsa-miR-361-5p ABL2 0.97 0 -0.32 0.04554 mirMAP -0.15 0.00146 NA
28 hsa-miR-378a-3p ABL2 -0.11 0.71619 -0.32 0.04554 mirMAP -0.16 0 NA
29 hsa-miR-378c ABL2 -0.15 0.56427 -0.32 0.04554 mirMAP -0.12 3.0E-5 NA
30 hsa-miR-450b-5p ABLIM1 1.69 0 -1.72 0 miRNATAP -0.14 0.00511 NA
31 hsa-miR-339-5p ABLIM2 2.69 0 -1.01 0.01362 miRanda -0.12 0.04303 NA
32 hsa-miR-374b-5p ABR 0.07 0.72267 -0.82 1.0E-5 miRNATAP -0.17 0.00057 NA
33 hsa-miR-493-5p ABR 0.85 0.00529 -0.82 1.0E-5 miRNATAP -0.13 1.0E-5 NA
34 hsa-miR-542-3p ABR 1.19 0 -0.82 1.0E-5 miRanda -0.16 2.0E-5 NA
35 hsa-miR-361-5p ACACB 0.97 0 -2.93 0 miRanda -0.48 0 NA
36 hsa-miR-542-3p ACACB 1.19 0 -2.93 0 miRanda -0.26 0.00023 NA
37 hsa-miR-23a-3p ACADSB 1 0 -1 0.00017 mirMAP -0.34 0 NA
38 hsa-miR-23b-3p ACAT1 -0.25 0.1502 -1.05 0 miRNAWalker2 validate -0.23 9.0E-5 NA
39 hsa-miR-23a-3p ACER2 1 0 0.02 0.97526 MirTarget -0.32 0.03463 NA
40 hsa-miR-23b-3p ACER3 -0.25 0.1502 -0.12 0.46232 MirTarget -0.15 0.00165 NA
41 hsa-miR-217 ACOX1 0.61 0.19935 0.36 0.1677 mirMAP -0.11 7.0E-5 NA
42 hsa-miR-23a-3p ACOX1 1 0 0.36 0.1677 mirMAP -0.29 3.0E-5 NA
43 hsa-miR-217 ACOXL 0.61 0.19935 0.6 0.42406 miRanda -0.2 0.01075 NA
44 hsa-miR-23a-3p ACSS1 1 0 -0.38 0.19224 MirTarget -0.37 0 NA
45 hsa-miR-378a-3p ACTB -0.11 0.71619 -0.54 0.00046 miRNAWalker2 validate -0.18 0 NA
46 hsa-miR-374a-5p ACTBL2 0.48 0.0043 1.68 0.00368 mirMAP -0.36 0.03367 NA
47 hsa-miR-361-5p ACTC1 0.97 0 -7.19 0 miRanda; miRNATAP -3.21 0 NA
48 hsa-miR-450b-5p ACTC1 1.69 0 -7.19 0 mirMAP -0.64 0.0008 NA
49 hsa-miR-218-5p ACTN1 -0.57 0.0552 -1.05 0.00011 miRNAWalker2 validate; miRNATAP -0.1 0.02025 NA
50 hsa-miR-374a-5p ACTN1 0.48 0.0043 -1.05 0.00011 MirTarget -0.47 0 NA
51 hsa-miR-450b-5p ACTN1 1.69 0 -1.05 0.00011 miRNATAP -0.12 0.01696 NA
52 hsa-miR-944 ACTN2 2.91 0 -3.37 0 mirMAP -0.45 0 NA
53 hsa-miR-361-5p ACTN4 0.97 0 -0.06 0.65476 miRanda -0.18 1.0E-5 NA
54 hsa-miR-145-5p ACVR1B -1.55 0 0.35 0.04863 MirTarget; miRNATAP -0.17 0 NA
55 hsa-miR-142-3p ACVR2A 2.75 0 -0.44 0.02646 MirTarget; PITA; miRanda; miRNATAP -0.2 0 NA
56 hsa-miR-223-3p ACVR2A 0.39 0.34596 -0.44 0.02646 MirTarget -0.19 0 NA
57 hsa-miR-493-5p ACVR2A 0.85 0.00529 -0.44 0.02646 miRNATAP -0.12 0.00011 NA
58 hsa-miR-374b-5p ADAM10 0.07 0.72267 0.67 0.00766 MirTarget; mirMAP -0.2 0.00316 NA
59 hsa-miR-361-5p ADAM12 0.97 0 0.88 0.05623 miRanda -0.82 0 NA
60 hsa-miR-23b-3p ADAM19 -0.25 0.1502 -1.06 0.01895 miRNATAP -0.44 0.00056 NA
61 hsa-miR-361-5p ADAM19 0.97 0 -1.06 0.01895 miRanda -1.17 0 NA
62 hsa-miR-142-3p ADAM22 2.75 0 -1.12 0.02589 miRanda -0.15 0.01192 NA
63 hsa-miR-224-5p ADAM22 2.94 0 -1.12 0.02589 MirTarget -0.15 0.00075 NA
64 hsa-miR-452-5p ADAM22 1.37 0.00171 -1.12 0.02589 MirTarget -0.16 0.00419 NA
65 hsa-miR-629-5p ADAM22 2.1 0 -1.12 0.02589 mirMAP -0.25 0.00539 NA
66 hsa-miR-944 ADAM22 2.91 0 -1.12 0.02589 mirMAP -0.23 0 NA
67 hsa-miR-361-5p ADAM28 0.97 0 -0.73 0.15943 mirMAP -0.49 0.00113 NA
68 hsa-miR-339-5p ADAM33 2.69 0 -4.48 0 miRanda -0.5 0 NA
69 hsa-miR-378a-3p ADAMDEC1 -0.11 0.71619 0.24 0.71291 MirTarget -0.54 0 NA
70 hsa-miR-944 ADAMTS12 2.91 0 0.14 0.80728 mirMAP -0.29 0 NA
71 hsa-miR-374a-5p ADAMTS16 0.48 0.0043 -1.54 0.01905 mirMAP -0.53 0.00552 NA
72 hsa-miR-142-3p ADAMTS19 2.75 0 -2.99 0 miRanda -0.43 0 NA
73 hsa-miR-224-5p ADAMTS2 2.94 0 -0.77 0.15763 mirMAP -0.21 1.0E-5 NA
74 hsa-miR-944 ADAMTS3 2.91 0 -1.18 0.00448 PITA; mirMAP -0.25 0 NA
75 hsa-miR-128-3p ADAMTS4 1.64 0 -2.17 0 miRNAWalker2 validate -0.55 0 NA
76 hsa-miR-339-5p ADAMTS4 2.69 0 -2.17 0 miRanda -0.35 0 NA
77 hsa-miR-361-5p ADAMTS5 0.97 0 -2.16 0 PITA; miRanda -0.64 0 NA
78 hsa-miR-374a-5p ADAMTS5 0.48 0.0043 -2.16 0 mirMAP -0.22 0.0194 NA
79 hsa-miR-452-5p ADAMTS5 1.37 0.00171 -2.16 0 mirMAP; miRNATAP -0.14 0.00017 NA
80 hsa-miR-944 ADAMTS5 2.91 0 -2.16 0 miRNATAP -0.18 0 NA
81 hsa-miR-23b-3p ADAMTS6 -0.25 0.1502 -0.88 0.01914 MirTarget; miRNATAP -0.42 7.0E-5 NA
82 hsa-miR-450b-5p ADAMTS8 1.69 0 -4.33 0 MirTarget; PITA; miRNATAP -0.49 0 NA
83 hsa-miR-339-5p ADAMTSL1 2.69 0 -2.52 0 miRanda -0.3 1.0E-5 NA
84 hsa-miR-944 ADAMTSL1 2.91 0 -2.52 0 PITA; miRNATAP -0.42 0 NA
85 hsa-miR-374a-5p ADAMTSL3 0.48 0.0043 -5.11 0 MirTarget; mirMAP -0.34 0.04116 NA
86 hsa-miR-339-5p ADAMTSL4 2.69 0 -1.86 9.0E-5 miRanda -0.21 0.00157 NA
87 hsa-miR-542-3p ADAMTSL5 1.19 0 -0.41 0.32739 MirTarget; miRanda -0.19 0.03477 NA
88 hsa-miR-224-5p ADARB1 2.94 0 -1.93 0 mirMAP -0.2 0 NA
89 hsa-miR-450b-5p ADARB1 1.69 0 -1.93 0 MirTarget; miRNATAP -0.13 0.01728 NA
90 hsa-miR-452-5p ADARB1 1.37 0.00171 -1.93 0 mirMAP -0.21 0 NA
91 hsa-miR-944 ADARB1 2.91 0 -1.93 0 PITA; miRNATAP -0.25 0 NA
92 hsa-miR-23a-3p ADCY1 1 0 -0.16 0.70518 MirTarget -0.39 0.00047 NA
93 hsa-miR-128-3p ADCY2 1.64 0 -3.87 0 MirTarget -0.89 0 NA
94 hsa-miR-361-5p ADCY2 0.97 0 -3.87 0 MirTarget; PITA; miRanda; miRNATAP -1.04 0 NA
95 hsa-miR-944 ADCY2 2.91 0 -3.87 0 mirMAP -0.35 0 NA
96 hsa-miR-450b-5p ADCY5 1.69 0 -5.17 0 miRNATAP -0.49 4.0E-5 NA
97 hsa-miR-944 ADCY5 2.91 0 -5.17 0 miRNATAP -0.47 0 NA
98 hsa-miR-493-5p ADCY6 0.85 0.00529 -0.13 0.52489 miRNATAP -0.12 0.0003 NA
99 hsa-miR-361-5p ADCY9 0.97 0 -1.5 0 miRanda -0.65 0 NA
100 hsa-miR-374a-5p ADCY9 0.48 0.0043 -1.5 0 mirMAP -0.34 1.0E-5 NA
101 hsa-miR-542-3p ADCY9 1.19 0 -1.5 0 miRanda -0.15 0.00784 NA
102 hsa-miR-944 ADCY9 2.91 0 -1.5 0 PITA -0.13 0 NA
103 hsa-miR-224-5p ADCYAP1 2.94 0 -3.51 0 mirMAP -0.27 0 NA
104 hsa-miR-23a-3p ADCYAP1 1 0 -3.51 0 mirMAP -0.84 0 NA
105 hsa-miR-361-5p ADCYAP1 0.97 0 -3.51 0 miRanda -0.98 0 NA
106 hsa-miR-450b-5p ADCYAP1 1.69 0 -3.51 0 PITA -0.32 0.0016 NA
107 hsa-miR-378c ADD2 -0.15 0.56427 -0.72 0.25015 miRNATAP -0.4 0.00052 NA
108 hsa-miR-23a-3p ADH1B 1 0 -7.89 0 mirMAP -2.35 0 NA
109 hsa-miR-450b-5p ADH1B 1.69 0 -7.89 0 MirTarget -0.55 0.00087 NA
110 hsa-miR-144-5p ADIPOQ 0.2 0.61856 -5.02 0 mirMAP -0.22 0.03076 NA
111 hsa-miR-339-5p ADIPOQ 2.69 0 -5.02 0 miRanda -0.54 1.0E-5 NA
112 hsa-miR-218-5p ADIPOR2 -0.57 0.0552 0.21 0.11195 MirTarget; miRNATAP -0.11 0 NA
113 hsa-miR-361-5p ADORA1 0.97 0 0.39 0.31104 miRanda -0.57 0 NA
114 hsa-miR-339-5p ADRA2A 2.69 0 -2.58 0 miRanda -0.36 0 NA
115 hsa-miR-361-5p ADRA2A 0.97 0 -2.58 0 miRanda -0.88 0 NA
116 hsa-miR-452-5p ADRA2A 1.37 0.00171 -2.58 0 miRNATAP -0.23 0 NA
117 hsa-miR-142-3p ADRA2C 2.75 0 -1.55 0.00834 miRanda -0.21 0.00311 NA
118 hsa-miR-450b-5p ADRB2 1.69 0 -1.96 1.0E-5 MirTarget -0.33 4.0E-5 NA
119 hsa-miR-339-5p AES 2.69 0 -0.34 0.05857 miRanda -0.11 3.0E-5 NA
120 hsa-miR-450b-5p AFAP1 1.69 0 -0.98 0.00012 mirMAP -0.13 0.00672 NA
121 hsa-miR-142-3p AFF1 2.75 0 -0.53 0.00163 MirTarget; PITA; miRanda; miRNATAP -0.1 0 NA
122 hsa-miR-23a-3p AFF1 1 0 -0.53 0.00163 mirMAP; miRNATAP -0.18 5.0E-5 NA
123 hsa-miR-23a-3p AFF2 1 0 -1.73 0.00201 mirMAP -0.41 0.0069 NA
124 hsa-miR-31-5p AFF2 3.59 0 -1.73 0.00201 mirMAP -0.21 0 NA
125 hsa-miR-944 AFF2 2.91 0 -1.73 0.00201 mirMAP -0.12 0.00978 NA
126 hsa-miR-128-3p AFF3 1.64 0 -5 0 MirTarget -0.88 0 NA
127 hsa-miR-224-5p AFF3 2.94 0 -5 0 MirTarget -0.33 0 NA
128 hsa-miR-450b-5p AFF3 1.69 0 -5 0 MirTarget; PITA; miRNATAP -0.43 1.0E-5 NA
129 hsa-miR-944 AFF3 2.91 0 -5 0 mirMAP -0.42 0 NA
130 hsa-miR-128-3p AFF4 1.64 0 -0.82 0 miRNAWalker2 validate; MirTarget -0.11 0.00079 NA
131 hsa-miR-361-5p AFF4 0.97 0 -0.82 0 miRanda -0.1 0.02408 NA
132 hsa-miR-374a-5p AFF4 0.48 0.0043 -0.82 0 MirTarget; miRNATAP -0.13 0.0038 NA
133 hsa-miR-374b-5p AFF4 0.07 0.72267 -0.82 0 miRNAWalker2 validate; MirTarget; miRNATAP -0.1 0.01279 NA
134 hsa-miR-217 AGAP11 0.61 0.19935 -0.01 0.97979 miRanda -0.24 8.0E-5 NA
135 hsa-miR-361-5p AGPS 0.97 0 -0.1 0.48101 miRanda; miRNATAP -0.13 0.00105 NA
136 hsa-miR-944 AGTR1 2.91 0 -4.49 0 PITA -0.4 0 NA
137 hsa-miR-374b-5p AHDC1 0.07 0.72267 -0.69 6.0E-5 miRNATAP -0.19 3.0E-5 NA
138 hsa-miR-361-5p AHNAK 0.97 0 -1.66 0 miRanda -0.55 0 NA
139 hsa-miR-142-3p AHR 2.75 0 0.16 0.56833 miRanda -0.1 0.00243 NA
140 hsa-miR-299-5p AHR -0.27 0.38683 0.16 0.56833 miRNATAP -0.15 0.00048 NA
141 hsa-miR-361-5p AIDA 0.97 0 -0.31 0.01307 miRanda -0.22 0 NA
142 hsa-miR-224-5p AIF1L 2.94 0 -1.46 0.00033 mirMAP -0.13 0.00032 NA
143 hsa-miR-361-5p AJAP1 0.97 0 -1.65 0.0004 miRanda -0.38 0.0057 NA
144 hsa-miR-493-5p AKAP1 0.85 0.00529 -0.34 0.0302 miRNATAP -0.11 1.0E-5 NA
145 hsa-miR-361-5p AKAP11 0.97 0 -0.8 0 mirMAP -0.16 0.00083 NA
146 hsa-miR-450b-5p AKAP11 1.69 0 -0.8 0 mirMAP -0.1 0.00074 NA
147 hsa-miR-542-3p AKAP11 1.19 0 -0.8 0 miRNATAP -0.11 0.00186 NA
148 hsa-miR-23a-3p AKAP12 1 0 -2.95 0 miRNATAP -0.71 0 NA
149 hsa-miR-361-5p AKAP12 0.97 0 -2.95 0 miRanda -0.63 0 NA
150 hsa-miR-339-5p AKAP13 2.69 0 -1.15 0 miRanda -0.2 0 NA
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 470 1672 2.979e-49 1.386e-45
2 REGULATION OF CELL DIFFERENTIATION 430 1492 6.74e-48 1.568e-44
3 NEUROGENESIS 391 1402 1.072e-39 1.662e-36
4 REGULATION OF CELLULAR COMPONENT MOVEMENT 256 771 2.429e-39 2.826e-36
5 CELL DEVELOPMENT 387 1426 2.198e-36 2.045e-33
6 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 380 1395 4.382e-36 3.398e-33
7 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 326 1142 4.68e-35 3.111e-32
8 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 296 1021 4.242e-33 2.467e-30
9 CARDIOVASCULAR SYSTEM DEVELOPMENT 246 788 5.996e-33 2.79e-30
10 CIRCULATORY SYSTEM DEVELOPMENT 246 788 5.996e-33 2.79e-30
11 REGULATION OF CELL DEVELOPMENT 254 836 6.594e-32 2.789e-29
12 TISSUE DEVELOPMENT 390 1518 4.013e-31 1.556e-28
13 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 413 1656 5.204e-30 1.863e-27
14 POSITIVE REGULATION OF CELL DIFFERENTIATION 246 823 1.036e-29 3.444e-27
15 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 446 1848 4.617e-29 1.432e-26
16 LOCOMOTION 302 1114 3.592e-28 1.045e-25
17 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 333 1275 7.323e-28 2.004e-25
18 POSITIVE REGULATION OF CELL COMMUNICATION 382 1532 1.137e-27 2.939e-25
19 POSITIVE REGULATION OF RESPONSE TO STIMULUS 455 1929 2.567e-27 6.286e-25
20 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 235 799 2.735e-27 6.364e-25
21 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 273 983 3.033e-27 6.721e-25
22 NEURON DIFFERENTIATION 250 874 5.133e-27 1.082e-24
23 REGULATION OF CELL PROLIFERATION 373 1496 5.349e-27 1.082e-24
24 RESPONSE TO ENDOGENOUS STIMULUS 364 1450 6.285e-27 1.219e-24
25 VASCULATURE DEVELOPMENT 160 469 2.995e-26 5.574e-24
26 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 232 801 6.332e-26 1.133e-23
27 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 221 750 8.13e-26 1.401e-23
28 POSITIVE REGULATION OF MOLECULAR FUNCTION 424 1791 1.002e-25 1.608e-23
29 RESPONSE TO OXYGEN CONTAINING COMPOUND 347 1381 9.92e-26 1.608e-23
30 REGULATION OF NEURON DIFFERENTIATION 178 554 1.29e-25 2.001e-23
31 BIOLOGICAL ADHESION 278 1032 1.782e-25 2.675e-23
32 INTRACELLULAR SIGNAL TRANSDUCTION 380 1572 9.064e-25 1.318e-22
33 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 271 1008 1.059e-24 1.493e-22
34 CELL MOTILITY 234 835 5.464e-24 7.264e-22
35 LOCALIZATION OF CELL 234 835 5.464e-24 7.264e-22
36 REGULATION OF CELL PROJECTION ORGANIZATION 174 558 1.943e-23 2.511e-21
37 REGULATION OF TRANSPORT 418 1804 2.154e-23 2.709e-21
38 REGULATION OF CELL MORPHOGENESIS 171 552 1.046e-22 1.281e-20
39 NEURON PROJECTION DEVELOPMENT 169 545 1.668e-22 1.99e-20
40 NEURON DEVELOPMENT 199 687 2.41e-22 2.803e-20
41 REGULATION OF PHOSPHORUS METABOLIC PROCESS 379 1618 4.704e-22 5.339e-20
42 POSITIVE REGULATION OF LOCOMOTION 140 420 4.989e-22 5.527e-20
43 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 198 689 8.581e-22 9.285e-20
44 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 160 513 1.208e-21 1.278e-19
45 POSITIVE REGULATION OF CATALYTIC ACTIVITY 359 1518 1.251e-21 1.294e-19
46 RESPONSE TO WOUNDING 170 563 2.84e-21 2.873e-19
47 BLOOD VESSEL MORPHOGENESIS 125 364 4.943e-21 4.894e-19
48 RESPONSE TO NITROGEN COMPOUND 230 859 8.364e-21 8.108e-19
49 NEURON PROJECTION MORPHOGENESIS 133 402 1.161e-20 1.092e-18
50 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 404 1784 1.173e-20 1.092e-18
51 REGULATION OF NEURON PROJECTION DEVELOPMENT 134 408 1.723e-20 1.572e-18
52 REGULATION OF PROTEIN MODIFICATION PROCESS 389 1710 3.053e-20 2.732e-18
53 CELLULAR COMPONENT MORPHOGENESIS 236 900 4.488e-20 3.94e-18
54 POSITIVE REGULATION OF GENE EXPRESSION 392 1733 6.058e-20 5.22e-18
55 POSITIVE REGULATION OF CELL DEVELOPMENT 146 472 1.76e-19 1.489e-17
56 MUSCLE STRUCTURE DEVELOPMENT 137 432 2.109e-19 1.752e-17
57 NEGATIVE REGULATION OF CELL DIFFERENTIATION 175 609 2.267e-19 1.851e-17
58 REGULATION OF CELL DEATH 342 1472 2.664e-19 2.137e-17
59 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 115 337 3.3e-19 2.603e-17
60 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 320 1360 6.13e-19 4.754e-17
61 HEAD DEVELOPMENT 194 709 8.819e-19 6.727e-17
62 HEART DEVELOPMENT 143 466 9.235e-19 6.821e-17
63 NEGATIVE REGULATION OF CELL COMMUNICATION 288 1192 9.21e-19 6.821e-17
64 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 258 1036 1.178e-18 8.436e-17
65 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 258 1036 1.178e-18 8.436e-17
66 CENTRAL NERVOUS SYSTEM DEVELOPMENT 226 872 1.339e-18 9.442e-17
67 CELLULAR RESPONSE TO NITROGEN COMPOUND 151 505 1.389e-18 9.646e-17
68 POSITIVE REGULATION OF CELL PROLIFERATION 214 814 2.038e-18 1.394e-16
69 WOUND HEALING 143 470 2.143e-18 1.445e-16
70 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 398 1805 3.11e-18 2.067e-16
71 POSITIVE REGULATION OF HYDROLASE ACTIVITY 230 905 8.101e-18 5.309e-16
72 ORGAN MORPHOGENESIS 217 841 1.174e-17 7.588e-16
73 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 134 437 1.258e-17 8.017e-16
74 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 239 957 1.71e-17 1.076e-15
75 RESPONSE TO ORGANIC CYCLIC COMPOUND 231 917 2.094e-17 1.299e-15
76 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 247 1004 3.408e-17 2.086e-15
77 REGULATION OF CELL ADHESION 173 629 4.26e-17 2.574e-15
78 SINGLE ORGANISM BEHAVIOR 121 384 4.824e-17 2.878e-15
79 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 274 1152 6.272e-17 3.694e-15
80 REGULATION OF SYSTEM PROCESS 147 507 8.004e-17 4.655e-15
81 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 335 1492 1.452e-16 8.342e-15
82 REGULATION OF BODY FLUID LEVELS 146 506 1.617e-16 9.173e-15
83 BEHAVIOR 148 516 1.76e-16 9.867e-15
84 TAXIS 137 464 1.799e-16 9.963e-15
85 CELL PROJECTION ORGANIZATION 225 902 1.859e-16 1.018e-14
86 RESPONSE TO LIPID 222 888 2.3e-16 1.244e-14
87 POSITIVE REGULATION OF TRANSPORT 231 936 2.66e-16 1.423e-14
88 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 219 876 3.717e-16 1.966e-14
89 NEGATIVE REGULATION OF CELL PROLIFERATION 173 643 4.213e-16 2.203e-14
90 REGULATION OF GTPASE ACTIVITY 179 673 4.28e-16 2.213e-14
91 RESPONSE TO HORMONE 222 893 4.484e-16 2.293e-14
92 SKELETAL SYSTEM DEVELOPMENT 134 455 4.857e-16 2.457e-14
93 MUSCLE TISSUE DEVELOPMENT 94 275 5.346e-16 2.675e-14
94 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 115 368 5.709e-16 2.826e-14
95 POSITIVE REGULATION OF NEURON DIFFERENTIATION 101 306 6.315e-16 3.093e-14
96 PROTEIN PHOSPHORYLATION 231 944 7.464e-16 3.618e-14
97 EPITHELIUM DEVELOPMENT 231 945 8.478e-16 4.067e-14
98 RESPONSE TO EXTERNAL STIMULUS 390 1821 9.863e-16 4.683e-14
99 FOREBRAIN DEVELOPMENT 112 357 1.01e-15 4.745e-14
100 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 142 498 1.246e-15 5.795e-14
101 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 266 1135 1.301e-15 5.995e-14
102 CELLULAR RESPONSE TO LIPID 133 457 1.764e-15 8.045e-14
103 REGULATION OF HYDROLASE ACTIVITY 300 1327 2.694e-15 1.217e-13
104 REGULATION OF MAPK CASCADE 174 660 2.735e-15 1.224e-13
105 REGULATION OF CELLULAR COMPONENT BIOGENESIS 195 767 2.863e-15 1.269e-13
106 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 82 232 4.576e-15 2.008e-13
107 ANGIOGENESIS 96 293 5.6e-15 2.435e-13
108 TUBE DEVELOPMENT 151 552 7.43e-15 3.201e-13
109 REGULATION OF ION TRANSPORT 158 592 1.759e-14 7.507e-13
110 REGULATION OF MEMBRANE POTENTIAL 106 343 1.819e-14 7.694e-13
111 REGULATION OF METAL ION TRANSPORT 102 325 1.883e-14 7.894e-13
112 REGULATION OF EPITHELIAL CELL PROLIFERATION 93 285 1.967e-14 8.172e-13
113 CELLULAR RESPONSE TO HORMONE STIMULUS 149 552 3.702e-14 1.524e-12
114 REGULATION OF KINASE ACTIVITY 193 776 3.965e-14 1.618e-12
115 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 186 740 4.106e-14 1.661e-12
116 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 96 303 5.802e-14 2.327e-12
117 REGULATION OF CELLULAR LOCALIZATION 284 1277 1.326e-13 5.275e-12
118 POSITIVE REGULATION OF KINASE ACTIVITY 133 482 1.537e-13 6.061e-12
119 REGULATION OF OSSIFICATION 66 178 1.614e-13 6.31e-12
120 UROGENITAL SYSTEM DEVELOPMENT 94 299 1.781e-13 6.905e-12
121 REGULATION OF BLOOD CIRCULATION 93 295 1.994e-13 7.669e-12
122 COGNITION 83 251 2.191e-13 8.355e-12
123 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 129 465 2.347e-13 8.878e-12
124 RESPONSE TO GROWTH FACTOR 131 475 2.448e-13 9.187e-12
125 RESPONSE TO OXYGEN LEVELS 96 311 3.372e-13 1.255e-11
126 CELL PART MORPHOGENESIS 162 633 3.89e-13 1.436e-11
127 REGULATION OF CELL SUBSTRATE ADHESION 64 173 4.231e-13 1.55e-11
128 CONNECTIVE TISSUE DEVELOPMENT 69 194 4.716e-13 1.708e-11
129 TELENCEPHALON DEVELOPMENT 77 228 4.736e-13 1.708e-11
130 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 143 541 7.088e-13 2.518e-11
131 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 143 541 7.088e-13 2.518e-11
132 RESPONSE TO PEPTIDE 115 404 7.471e-13 2.614e-11
133 MODULATION OF SYNAPTIC TRANSMISSION 93 301 7.423e-13 2.614e-11
134 NEGATIVE REGULATION OF GENE EXPRESSION 319 1493 8.129e-13 2.823e-11
135 REGULATION OF DENDRITE DEVELOPMENT 50 120 8.407e-13 2.897e-11
136 REGULATION OF PROTEIN LOCALIZATION 221 950 8.786e-13 3.006e-11
137 ACTIN FILAMENT BASED PROCESS 124 450 1.145e-12 3.889e-11
138 POSITIVE REGULATION OF CELL DEATH 155 605 1.16e-12 3.91e-11
139 CHEMICAL HOMEOSTASIS 206 874 1.488e-12 4.982e-11
140 MUSCLE CELL DIFFERENTIATION 78 237 1.516e-12 5.037e-11
141 PALLIUM DEVELOPMENT 58 153 1.604e-12 5.292e-11
142 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 401 1977 1.962e-12 6.43e-11
143 GROWTH 115 410 2.165e-12 7.045e-11
144 POSITIVE REGULATION OF MAPK CASCADE 127 470 2.715e-12 8.773e-11
145 REGULATION OF ACTIN FILAMENT BASED PROCESS 94 312 2.831e-12 9.085e-11
146 NEGATIVE REGULATION OF CELL ADHESION 74 223 3.578e-12 1.14e-10
147 NEGATIVE REGULATION OF LOCOMOTION 83 263 3.671e-12 1.162e-10
148 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 76 232 3.795e-12 1.193e-10
149 NEGATIVE REGULATION OF TRANSPORT 124 458 4.266e-12 1.332e-10
150 TISSUE MORPHOGENESIS 139 533 4.362e-12 1.353e-10
151 POSITIVE REGULATION OF OSSIFICATION 39 84 4.648e-12 1.432e-10
152 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 86 278 5.014e-12 1.529e-10
153 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 70 207 5.027e-12 1.529e-10
154 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 126 470 5.965e-12 1.802e-10
155 REGULATION OF EPITHELIAL CELL MIGRATION 60 166 7.093e-12 2.129e-10
156 NEURON PROJECTION GUIDANCE 69 205 9.101e-12 2.714e-10
157 CELL CELL SIGNALING 183 767 9.306e-12 2.758e-10
158 RESPONSE TO MECHANICAL STIMULUS 70 210 1.076e-11 3.169e-10
159 MORPHOGENESIS OF AN EPITHELIUM 111 400 1.092e-11 3.194e-10
160 IMMUNE SYSTEM PROCESS 398 1984 1.193e-11 3.47e-10
161 EMBRYO DEVELOPMENT 206 894 1.385e-11 4.003e-10
162 CELLULAR RESPONSE TO PEPTIDE 84 274 1.496e-11 4.297e-10
163 CELL ACTIVATION 144 568 1.71e-11 4.881e-10
164 REGULATION OF HOMEOSTATIC PROCESS 120 447 1.731e-11 4.912e-10
165 REGULATION OF ANATOMICAL STRUCTURE SIZE 125 472 1.763e-11 4.971e-10
166 REGULATION OF HEART CONTRACTION 72 221 1.86e-11 5.214e-10
167 HOMEOSTATIC PROCESS 285 1337 2.04e-11 5.685e-10
168 EXTRACELLULAR STRUCTURE ORGANIZATION 90 304 2.356e-11 6.527e-10
169 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 316 1517 2.602e-11 7.165e-10
170 DEVELOPMENTAL GROWTH 96 333 2.702e-11 7.396e-10
171 MUSCLE ORGAN DEVELOPMENT 84 277 2.798e-11 7.613e-10
172 IMMUNE SYSTEM DEVELOPMENT 146 582 2.836e-11 7.671e-10
173 RESPONSE TO ALCOHOL 102 362 2.852e-11 7.671e-10
174 REGULATION OF ION HOMEOSTASIS 67 201 2.961e-11 7.919e-10
175 RESPONSE TO ABIOTIC STIMULUS 228 1024 3.692e-11 9.651e-10
176 CARDIOCYTE DIFFERENTIATION 41 96 3.66e-11 9.651e-10
177 NEGATIVE REGULATION OF PHOSPHORYLATION 114 422 3.645e-11 9.651e-10
178 HEMOSTASIS 91 311 3.684e-11 9.651e-10
179 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 117 437 3.732e-11 9.702e-10
180 RHYTHMIC PROCESS 88 298 4.543e-11 1.174e-09
181 PHOSPHORYLATION 264 1228 4.822e-11 1.239e-09
182 REGULATION OF GROWTH 155 633 4.937e-11 1.262e-09
183 STRIATED MUSCLE CELL DIFFERENTIATION 60 173 5.085e-11 1.293e-09
184 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 68 208 5.638e-11 1.426e-09
185 REGULATION OF MUSCLE SYSTEM PROCESS 65 195 5.814e-11 1.462e-09
186 REGULATION OF TRANSFERASE ACTIVITY 213 946 5.87e-11 1.468e-09
187 REGULATION OF TRANSMEMBRANE TRANSPORT 114 426 6.87e-11 1.71e-09
188 EMBRYONIC MORPHOGENESIS 136 539 8.931e-11 2.21e-09
189 MORPHOGENESIS OF A BRANCHING STRUCTURE 58 167 9.958e-11 2.452e-09
190 REGULATION OF VASCULATURE DEVELOPMENT 73 233 1.05e-10 2.571e-09
191 REGULATION OF IMMUNE SYSTEM PROCESS 293 1403 1.124e-10 2.739e-09
192 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 33 70 1.215e-10 2.944e-09
193 CIRCULATORY SYSTEM PROCESS 101 366 1.306e-10 3.15e-09
194 RESPONSE TO STEROID HORMONE 127 497 1.568e-10 3.761e-09
195 REGULATION OF SYNAPTIC PLASTICITY 51 140 1.884e-10 4.495e-09
196 REGULATION OF RESPONSE TO WOUNDING 110 413 2.008e-10 4.766e-09
197 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 207 926 2.159e-10 5.1e-09
198 NEGATIVE REGULATION OF CELL DEATH 197 872 2.373e-10 5.576e-09
199 CEREBRAL CORTEX DEVELOPMENT 42 105 2.598e-10 6.075e-09
200 NEGATIVE REGULATION OF CELL DEVELOPMENT 87 303 2.859e-10 6.65e-09
201 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 71 229 3.171e-10 7.34e-09
202 REGULATION OF TRANSPORTER ACTIVITY 64 198 3.492e-10 8.044e-09
203 SENSORY ORGAN DEVELOPMENT 125 493 3.726e-10 8.54e-09
204 REGULATION OF MAP KINASE ACTIVITY 90 319 3.844e-10 8.768e-09
205 GLOMERULUS DEVELOPMENT 26 49 4.223e-10 9.586e-09
206 CARTILAGE DEVELOPMENT 52 147 4.29e-10 9.69e-09
207 REGULATION OF SECRETION 164 699 4.432e-10 9.963e-09
208 SECOND MESSENGER MEDIATED SIGNALING 55 160 4.672e-10 1.045e-08
209 MUSCLE SYSTEM PROCESS 82 282 4.732e-10 1.054e-08
210 POSITIVE REGULATION OF ION TRANSPORT 72 236 5.316e-10 1.178e-08
211 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 148 616 5.681e-10 1.253e-08
212 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 40 100 6.882e-10 1.51e-08
213 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 56 166 7.297e-10 1.594e-08
214 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 96 352 7.393e-10 1.6e-08
215 ION HOMEOSTASIS 140 576 7.36e-10 1.6e-08
216 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 53 154 9.16e-10 1.973e-08
217 REGULATION OF CHEMOTAXIS 59 180 9.205e-10 1.974e-08
218 REGULATION OF RESPONSE TO STRESS 299 1468 1.19e-09 2.539e-08
219 MESENCHYME DEVELOPMENT 61 190 1.211e-09 2.572e-08
220 CELL SUBSTRATE ADHESION 55 164 1.319e-09 2.79e-08
221 RESPONSE TO DRUG 111 431 1.386e-09 2.919e-08
222 NEURON MIGRATION 42 110 1.418e-09 2.972e-08
223 REGULATION OF DEVELOPMENTAL GROWTH 82 289 1.712e-09 3.572e-08
224 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 40 103 1.936e-09 4.022e-08
225 REGULATION OF PROTEIN SECRETION 102 389 2.284e-09 4.724e-08
226 CELLULAR CHEMICAL HOMEOSTASIS 137 570 2.433e-09 5.009e-08
227 GLAND DEVELOPMENT 103 395 2.639e-09 5.409e-08
228 AMEBOIDAL TYPE CELL MIGRATION 52 154 2.812e-09 5.739e-08
229 CELL JUNCTION ORGANIZATION 59 185 2.986e-09 6.068e-08
230 STEM CELL DIFFERENTIATION 60 190 3.359e-09 6.796e-08
231 CARDIAC MUSCLE CELL DIFFERENTIATION 32 74 3.472e-09 6.994e-08
232 MULTI MULTICELLULAR ORGANISM PROCESS 65 213 3.577e-09 7.173e-08
233 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 98 372 3.61e-09 7.209e-08
234 REGULATION OF STEM CELL DIFFERENTIATION 42 113 3.668e-09 7.294e-08
235 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 165 724 3.725e-09 7.375e-08
236 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 48 138 3.763e-09 7.419e-08
237 TUBE MORPHOGENESIS 88 323 3.95e-09 7.754e-08
238 REGULATION OF CALCIUM ION TRANSPORT 64 209 4.042e-09 7.903e-08
239 RESPONSE TO CYTOKINE 163 714 4.083e-09 7.949e-08
240 OSSIFICATION 73 251 4.147e-09 8.041e-08
241 REGULATION OF ORGAN MORPHOGENESIS 71 242 4.492e-09 8.673e-08
242 REGULATION OF CELL MATRIX ADHESION 36 90 4.837e-09 9.301e-08
243 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 49 144 5.973e-09 1.144e-07
244 NEPHRON DEVELOPMENT 42 115 6.736e-09 1.279e-07
245 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 144 616 6.714e-09 1.279e-07
246 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 53 162 6.961e-09 1.317e-07
247 SKELETAL MUSCLE ORGAN DEVELOPMENT 47 137 9.014e-09 1.698e-07
248 CELL CELL ADHESION 142 608 9.101e-09 1.708e-07
249 REGULATION OF HEMOPOIESIS 85 314 1.003e-08 1.873e-07
250 FOREBRAIN CELL MIGRATION 28 62 1.016e-08 1.891e-07
251 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 103 406 1.266e-08 2.344e-07
252 APPENDAGE DEVELOPMENT 54 169 1.275e-08 2.344e-07
253 LIMB DEVELOPMENT 54 169 1.275e-08 2.344e-07
254 REGULATION OF MUSCLE CONTRACTION 49 147 1.285e-08 2.355e-07
255 REGULATION OF PROTEIN IMPORT 57 183 1.428e-08 2.606e-07
256 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 65 220 1.472e-08 2.676e-07
257 CELL PROLIFERATION 153 672 1.487e-08 2.692e-07
258 REGULATION OF DENDRITE MORPHOGENESIS 31 74 1.524e-08 2.731e-07
259 SINGLE ORGANISM CELL ADHESION 113 459 1.526e-08 2.731e-07
260 LEUKOCYTE DIFFERENTIATION 80 292 1.517e-08 2.731e-07
261 REGULATION OF CELLULAR COMPONENT SIZE 89 337 1.642e-08 2.927e-07
262 RENAL SYSTEM PROCESS 38 102 1.86e-08 3.304e-07
263 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 37 98 1.885e-08 3.334e-07
264 DIVALENT INORGANIC CATION HOMEOSTASIS 90 343 1.908e-08 3.362e-07
265 SECRETION 137 588 1.944e-08 3.414e-07
266 CELL CHEMOTAXIS 52 162 1.983e-08 3.469e-07
267 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 79 289 2.073e-08 3.612e-07
268 CELLULAR HOMEOSTASIS 153 676 2.245e-08 3.897e-07
269 REGULATION OF PHOSPHOLIPASE ACTIVITY 28 64 2.4e-08 4.152e-07
270 REGULATION OF PEPTIDE TRANSPORT 72 256 2.455e-08 4.23e-07
271 REGULATION OF POTASSIUM ION TRANSPORT 33 83 2.496e-08 4.286e-07
272 CELL DEATH 211 1001 2.536e-08 4.337e-07
273 EMBRYONIC ORGAN DEVELOPMENT 102 406 2.547e-08 4.341e-07
274 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 24 50 2.623e-08 4.454e-07
275 EPITHELIAL CELL DIFFERENTIATION 119 495 2.69e-08 4.551e-07
276 REGULATION OF AXONOGENESIS 53 168 2.809e-08 4.735e-07
277 CARDIAC MUSCLE CELL ACTION POTENTIAL 20 37 2.928e-08 4.918e-07
278 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 58 191 2.963e-08 4.96e-07
279 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 41 116 2.997e-08 4.999e-07
280 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 73 262 3.009e-08 5e-07
281 REGULATION OF OSTEOBLAST DIFFERENTIATION 40 112 3.155e-08 5.225e-07
282 REGULATION OF CYTOPLASMIC TRANSPORT 116 481 3.345e-08 5.52e-07
283 REGULATION OF INTRACELLULAR TRANSPORT 142 621 3.717e-08 6.111e-07
284 REGULATION OF MYELOID CELL DIFFERENTIATION 56 183 3.792e-08 6.213e-07
285 MESENCHYMAL CELL DIFFERENTIATION 45 134 3.858e-08 6.298e-07
286 AGING 73 264 4.23e-08 6.882e-07
287 REGULATION OF MUSCLE CELL DIFFERENTIATION 49 152 4.314e-08 6.995e-07
288 REGULATION OF CELL SHAPE 46 139 4.541e-08 7.336e-07
289 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 56 184 4.675e-08 7.527e-07
290 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 186 867 4.752e-08 7.624e-07
291 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 20 38 5.321e-08 8.507e-07
292 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 44 131 5.409e-08 8.619e-07
293 REGULATION OF WNT SIGNALING PATHWAY 82 310 5.507e-08 8.746e-07
294 REGULATION OF ENDOTHELIAL CELL MIGRATION 40 114 5.543e-08 8.773e-07
295 CARDIAC MUSCLE TISSUE DEVELOPMENT 46 140 5.802e-08 9.152e-07
296 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 63 218 6.06e-08 9.525e-07
297 REGULATION OF FAT CELL DIFFERENTIATION 38 106 6.161e-08 9.619e-07
298 FAT CELL DIFFERENTIATION 38 106 6.161e-08 9.619e-07
299 LOCOMOTORY BEHAVIOR 55 181 6.515e-08 1.014e-06
300 REGULATION OF NEURON DEATH 70 252 6.544e-08 1.015e-06
301 CARDIAC CONDUCTION 32 82 6.823e-08 1.055e-06
302 EPITHELIAL CELL DEVELOPMENT 56 186 7.055e-08 1.087e-06
303 REGULATION OF ERK1 AND ERK2 CASCADE 67 238 7.128e-08 1.095e-06
304 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 28 67 7.985e-08 1.222e-06
305 CARDIAC CELL DEVELOPMENT 23 49 8.634e-08 1.317e-06
306 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 36 99 8.963e-08 1.358e-06
307 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 36 99 8.963e-08 1.358e-06
308 LEUKOCYTE MIGRATION 71 259 9.365e-08 1.415e-06
309 REGULATION OF SMOOTH MUSCLE CONTRACTION 26 60 9.568e-08 1.436e-06
310 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 26 60 9.568e-08 1.436e-06
311 KIDNEY EPITHELIUM DEVELOPMENT 42 125 1.064e-07 1.591e-06
312 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 24 53 1.07e-07 1.595e-06
313 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 17 30 1.284e-07 1.908e-06
314 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 31 80 1.316e-07 1.95e-06
315 REGULATION OF SYNAPSE ORGANIZATION 39 113 1.34e-07 1.979e-06
316 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 78 296 1.366e-07 2.011e-06
317 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 38 109 1.432e-07 2.101e-06
318 RESPONSE TO ESTROGEN 62 218 1.449e-07 2.12e-06
319 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 46 144 1.495e-07 2.181e-06
320 GLAND MORPHOGENESIS 35 97 1.68e-07 2.442e-06
321 PEPTIDYL TYROSINE MODIFICATION 55 186 1.785e-07 2.588e-06
322 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 19 37 1.918e-07 2.772e-06
323 MEMORY 35 98 2.244e-07 3.222e-06
324 MUSCLE CELL DEVELOPMENT 42 128 2.243e-07 3.222e-06
325 REPRODUCTIVE SYSTEM DEVELOPMENT 99 408 2.455e-07 3.514e-06
326 NEGATIVE REGULATION OF GROWTH 65 236 2.668e-07 3.808e-06
327 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 82 321 2.755e-07 3.92e-06
328 CELL JUNCTION ASSEMBLY 42 129 2.855e-07 4.049e-06
329 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 48 156 2.886e-07 4.082e-06
330 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 58 203 3.047e-07 4.296e-06
331 CELLULAR RESPONSE TO ACID CHEMICAL 52 175 3.226e-07 4.535e-06
332 CELLULAR RESPONSE TO OXYGEN LEVELS 45 143 3.295e-07 4.617e-06
333 REGULATION OF HORMONE SECRETION 70 262 3.353e-07 4.685e-06
334 PROTEIN LOCALIZATION 341 1805 3.472e-07 4.837e-06
335 ARTERY DEVELOPMENT 29 75 3.497e-07 4.858e-06
336 SPROUTING ANGIOGENESIS 21 45 3.55e-07 4.916e-06
337 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 220 1087 3.562e-07 4.918e-06
338 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 35 100 3.938e-07 5.422e-06
339 ADULT BEHAVIOR 43 135 4.109e-07 5.64e-06
340 REGULATED EXOCYTOSIS 62 224 4.134e-07 5.658e-06
341 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 33 92 4.389e-07 5.98e-06
342 RESPONSE TO PURINE CONTAINING COMPOUND 48 158 4.396e-07 5.98e-06
343 LEARNING 42 131 4.573e-07 6.167e-06
344 ACTIVATION OF PROTEIN KINASE ACTIVITY 73 279 4.569e-07 6.167e-06
345 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 42 131 4.573e-07 6.167e-06
346 RESPONSE TO REACTIVE OXYGEN SPECIES 55 191 4.628e-07 6.223e-06
347 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 27 68 4.708e-07 6.314e-06
348 CYTOSKELETON ORGANIZATION 176 838 4.843e-07 6.475e-06
349 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 23 53 5.054e-07 6.738e-06
350 LEUKOCYTE ACTIVATION 99 414 5.073e-07 6.744e-06
351 REGULATION OF HORMONE LEVELS 111 478 5.096e-07 6.755e-06
352 SYNAPSE ORGANIZATION 45 145 5.117e-07 6.764e-06
353 REGULATION OF CELL ACTIVATION 112 484 5.453e-07 7.188e-06
354 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 34 97 5.52e-07 7.255e-06
355 REGULATION OF PHOSPHOLIPASE C ACTIVITY 19 39 5.55e-07 7.271e-06
356 REGULATION OF NEURON APOPTOTIC PROCESS 55 192 5.563e-07 7.271e-06
357 MULTICELLULAR ORGANISMAL SIGNALING 40 123 5.615e-07 7.317e-06
358 RESPONSE TO OXIDATIVE STRESS 87 352 5.63e-07 7.317e-06
359 CYCLIC NUCLEOTIDE METABOLIC PROCESS 24 57 5.652e-07 7.325e-06
360 RESPIRATORY SYSTEM DEVELOPMENT 56 197 5.796e-07 7.492e-06
361 ACTIN FILAMENT BASED MOVEMENT 33 93 5.844e-07 7.533e-06
362 MEMBRANE DEPOLARIZATION 25 61 6.119e-07 7.865e-06
363 CELL MATRIX ADHESION 39 119 6.192e-07 7.938e-06
364 CELLULAR RESPONSE TO INSULIN STIMULUS 45 146 6.348e-07 8.115e-06
365 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 35 102 6.768e-07 8.628e-06
366 PLASMA MEMBRANE ORGANIZATION 57 203 7.171e-07 9.116e-06
367 BONE DEVELOPMENT 47 156 7.526e-07 9.542e-06
368 ACTION POTENTIAL 33 94 7.737e-07 9.782e-06
369 CALCIUM MEDIATED SIGNALING 32 90 8.184e-07 1.032e-05
370 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 12 18 8.316e-07 1.046e-05
371 REGULATION OF HEART RATE 31 86 8.585e-07 1.077e-05
372 FEMALE SEX DIFFERENTIATION 38 116 8.69e-07 1.087e-05
373 REGULATION OF PEPTIDE SECRETION 58 209 8.771e-07 1.094e-05
374 REGULATION OF MUSCLE TISSUE DEVELOPMENT 35 103 8.805e-07 1.095e-05
375 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 16 30 9.199e-07 1.141e-05
376 REGULATION OF INFLAMMATORY RESPONSE 75 294 9.249e-07 1.145e-05
377 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 28 74 9.306e-07 1.149e-05
378 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 71 274 9.628e-07 1.185e-05
379 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 48 162 9.873e-07 1.212e-05
380 POSITIVE REGULATION OF HEART GROWTH 15 27 1.012e-06 1.234e-05
381 RESPONSE TO INORGANIC SUBSTANCE 110 479 1.016e-06 1.234e-05
382 ARTERY MORPHOGENESIS 22 51 1.01e-06 1.234e-05
383 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 96 404 1.014e-06 1.234e-05
384 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 50 172 1.11e-06 1.345e-05
385 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 35 104 1.14e-06 1.378e-05
386 VESICLE MEDIATED TRANSPORT 243 1239 1.147e-06 1.383e-05
387 REGULATION OF LEUKOCYTE MIGRATION 45 149 1.191e-06 1.431e-05
388 SECRETION BY CELL 111 486 1.201e-06 1.436e-05
389 REGULATION OF LIPASE ACTIVITY 30 83 1.201e-06 1.436e-05
390 OVULATION CYCLE 37 113 1.22e-06 1.455e-05
391 DENDRITE DEVELOPMENT 29 79 1.245e-06 1.482e-05
392 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 39 122 1.259e-06 1.495e-05
393 SENSORY PERCEPTION OF PAIN 28 75 1.277e-06 1.508e-05
394 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 28 75 1.277e-06 1.508e-05
395 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 26 67 1.286e-06 1.515e-05
396 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 63 236 1.31e-06 1.54e-05
397 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 55 197 1.355e-06 1.588e-05
398 CAMP METABOLIC PROCESS 17 34 1.381e-06 1.615e-05
399 POSITIVE REGULATION OF MAP KINASE ACTIVITY 57 207 1.424e-06 1.66e-05
400 POSITIVE REGULATION OF SECRETION 89 370 1.445e-06 1.681e-05
401 HEART MORPHOGENESIS 58 212 1.452e-06 1.684e-05
402 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 19 41 1.462e-06 1.692e-05
403 OVULATION CYCLE PROCESS 31 88 1.521e-06 1.756e-05
404 POSITIVE REGULATION OF ENDOCYTOSIS 37 114 1.551e-06 1.786e-05
405 POSITIVE REGULATION OF CELL ADHESION 90 376 1.577e-06 1.812e-05
406 REGULATION OF DENDRITIC SPINE DEVELOPMENT 23 56 1.636e-06 1.866e-05
407 SYSTEM PROCESS 333 1785 1.629e-06 1.866e-05
408 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 23 56 1.636e-06 1.866e-05
409 CHONDROCYTE DIFFERENTIATION 24 60 1.725e-06 1.962e-05
410 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 28 76 1.738e-06 1.963e-05
411 RESPONSE TO ALKALOID 42 137 1.73e-06 1.963e-05
412 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 59 218 1.735e-06 1.963e-05
413 CELLULAR RESPONSE TO OXIDATIVE STRESS 52 184 1.748e-06 1.97e-05
414 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 25 64 1.775e-06 1.995e-05
415 WNT SIGNALING PATHWAY 85 351 1.848e-06 2.072e-05
416 POSITIVE REGULATION OF ORGAN GROWTH 18 38 1.855e-06 2.075e-05
417 PLATELET ACTIVATION 43 142 1.883e-06 2.097e-05
418 REGULATION OF FATTY ACID OXIDATION 15 28 1.881e-06 2.097e-05
419 REGULATION OF ENDOCYTOSIS 55 199 1.908e-06 2.118e-05
420 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 57 209 1.984e-06 2.198e-05
421 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 21 49 2.018e-06 2.23e-05
422 CELLULAR RESPONSE TO EXTERNAL STIMULUS 68 264 2.031e-06 2.24e-05
423 CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 13 22 2.106e-06 2.316e-05
424 EYE DEVELOPMENT 80 326 2.128e-06 2.336e-05
425 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 53 190 2.151e-06 2.354e-05
426 POSITIVE REGULATION OF CHEMOTAXIS 38 120 2.219e-06 2.424e-05
427 NEGATIVE REGULATION OF NEURON DEATH 49 171 2.229e-06 2.429e-05
428 RESPONSE TO INSULIN 56 205 2.3e-06 2.501e-05
429 RAS PROTEIN SIGNAL TRANSDUCTION 43 143 2.312e-06 2.508e-05
430 NEGATIVE REGULATION OF KINASE ACTIVITY 65 250 2.401e-06 2.598e-05
431 REGULATION OF ORGAN GROWTH 27 73 2.425e-06 2.618e-05
432 DIGESTIVE SYSTEM DEVELOPMENT 44 148 2.483e-06 2.674e-05
433 REGULATION OF CIRCADIAN RHYTHM 34 103 2.646e-06 2.836e-05
434 REGULATION OF MUSCLE ORGAN DEVELOPMENT 34 103 2.646e-06 2.836e-05
435 REGULATION OF CELL SIZE 49 172 2.675e-06 2.862e-05
436 REGULATION OF CHONDROCYTE DIFFERENTIATION 20 46 2.686e-06 2.867e-05
437 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 10 14 2.786e-06 2.946e-05
438 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 38 121 2.778e-06 2.946e-05
439 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 10 14 2.786e-06 2.946e-05
440 POSITIVE REGULATION OF FATTY ACID OXIDATION 10 14 2.786e-06 2.946e-05
441 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 30 86 2.815e-06 2.97e-05
442 SALIVARY GLAND DEVELOPMENT 16 32 2.829e-06 2.972e-05
443 REGULATION OF ORGAN FORMATION 16 32 2.829e-06 2.972e-05
444 RESPONSE TO KETONE 51 182 2.871e-06 3.008e-05
445 POSITIVE REGULATION OF HEMOPOIESIS 47 163 2.945e-06 3.073e-05
446 CELLULAR RESPONSE TO BIOTIC STIMULUS 47 163 2.945e-06 3.073e-05
447 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 41 135 2.979e-06 3.094e-05
448 CELL GROWTH 41 135 2.979e-06 3.094e-05
449 REGULATION OF ADHERENS JUNCTION ORGANIZATION 21 50 2.996e-06 3.105e-05
450 REGULATION OF LEUKOCYTE DIFFERENTIATION 61 232 3.274e-06 3.386e-05
451 RESPONSE TO ACID CHEMICAL 78 319 3.282e-06 3.386e-05
452 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 15 29 3.362e-06 3.461e-05
453 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 25 66 3.437e-06 3.507e-05
454 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 25 66 3.437e-06 3.507e-05
455 REGULATION OF CARDIAC CONDUCTION 25 66 3.437e-06 3.507e-05
456 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 24 62 3.435e-06 3.507e-05
457 REGULATION OF CYTOSKELETON ORGANIZATION 112 502 3.493e-06 3.557e-05
458 CEREBRAL CORTEX CELL MIGRATION 19 43 3.551e-06 3.608e-05
459 REGULATION OF CELLULAR PROTEIN LOCALIZATION 121 552 3.603e-06 3.653e-05
460 TISSUE REMODELING 30 87 3.693e-06 3.735e-05
461 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 17 36 3.783e-06 3.802e-05
462 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 17 36 3.783e-06 3.802e-05
463 POSITIVE REGULATION OF GROWTH 62 238 3.791e-06 3.802e-05
464 SEMAPHORIN PLEXIN SIGNALING PATHWAY 17 36 3.783e-06 3.802e-05
465 MUSCLE CONTRACTION 61 233 3.805e-06 3.807e-05
466 EXOCYTOSIS 76 310 3.929e-06 3.923e-05
467 MYELOID CELL DIFFERENTIATION 52 189 4.147e-06 4.132e-05
468 RESPONSE TO ESTRADIOL 43 146 4.202e-06 4.16e-05
469 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 13 23 4.186e-06 4.16e-05
470 REGULATION OF SYNAPSE ASSEMBLY 28 79 4.195e-06 4.16e-05
471 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 121 554 4.335e-06 4.282e-05
472 GLIOGENESIS 49 175 4.56e-06 4.496e-05
473 NEURON RECOGNITION 16 33 4.738e-06 4.661e-05
474 REGULATION OF CARTILAGE DEVELOPMENT 24 63 4.775e-06 4.688e-05
475 EAR DEVELOPMENT 53 195 4.979e-06 4.878e-05
476 INOSITOL LIPID MEDIATED SIGNALING 38 124 5.333e-06 5.213e-05
477 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 44 152 5.377e-06 5.245e-05
478 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 34 106 5.428e-06 5.283e-05
479 REGULATION OF LIPID METABOLIC PROCESS 70 282 5.89e-06 5.722e-05
480 REGULATION OF LEUKOCYTE PROLIFERATION 55 206 5.962e-06 5.78e-05
481 IMPORT INTO CELL 17 37 6.036e-06 5.827e-05
482 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 33 102 6.027e-06 5.827e-05
483 REGULATION OF CELL JUNCTION ASSEMBLY 25 68 6.418e-06 6.183e-05
484 OUTFLOW TRACT MORPHOGENESIS 22 56 6.558e-06 6.304e-05
485 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 23 60 6.63e-06 6.36e-05
486 ION TRANSPORT 242 1262 6.769e-06 6.481e-05
487 REGULATION OF SEQUESTERING OF CALCIUM ION 34 107 6.836e-06 6.531e-05
488 DEVELOPMENTAL CELL GROWTH 27 77 7.796e-06 7.418e-05
489 SINGLE ORGANISM CELLULAR LOCALIZATION 180 898 7.782e-06 7.418e-05
490 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 13 24 7.893e-06 7.496e-05
491 DEVELOPMENTAL MATURATION 52 193 7.984e-06 7.566e-05
492 REGULATION OF WOUND HEALING 38 126 8.094e-06 7.642e-05
493 REGULATION OF JNK CASCADE 45 159 8.097e-06 7.642e-05
494 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 56 213 8.13e-06 7.657e-05
495 REGULATION OF CELLULAR RESPONSE TO STRESS 144 691 8.171e-06 7.68e-05
496 CELLULAR RESPONSE TO CYTOKINE STIMULUS 129 606 8.202e-06 7.695e-05
497 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 36 117 8.428e-06 7.874e-05
498 MAMMARY GLAND DEVELOPMENT 36 117 8.428e-06 7.874e-05
499 REGULATION OF CELL GROWTH 90 391 8.595e-06 8.015e-05
500 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 23 61 9.161e-06 8.525e-05
501 REGULATION OF CELL PROJECTION ASSEMBLY 44 155 9.337e-06 8.671e-05
502 COLLAGEN FIBRIL ORGANIZATION 17 38 9.42e-06 8.714e-05
503 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 17 38 9.42e-06 8.714e-05
504 REGULATION OF CYTOKINE PRODUCTION 121 563 9.713e-06 8.968e-05
505 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 48 175 1.044e-05 9.621e-05
506 NEGATIVE REGULATION OF MOLECULAR FUNCTION 210 1079 1.057e-05 9.721e-05
507 CELLULAR MACROMOLECULE LOCALIZATION 236 1234 1.071e-05 9.827e-05
508 PROTEIN LOCALIZATION TO CELL PERIPHERY 43 151 1.076e-05 9.856e-05
509 REGULATION OF HEART GROWTH 18 42 1.079e-05 9.866e-05
510 CIRCADIAN RHYTHM 40 137 1.126e-05 0.0001027
511 REGENERATION 45 161 1.152e-05 0.0001049
512 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 25 70 1.159e-05 0.0001053
513 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 19 46 1.18e-05 0.000107
514 RIBONUCLEOTIDE CATABOLIC PROCESS 14 28 1.193e-05 0.0001078
515 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 28 1.193e-05 0.0001078
516 POSITIVE REGULATION OF LIPASE ACTIVITY 24 66 1.213e-05 0.0001092
517 REGULATION OF CARDIAC MUSCLE CONTRACTION 24 66 1.213e-05 0.0001092
518 RESPONSE TO MONOAMINE 16 35 1.228e-05 0.0001103
519 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 56 216 1.27e-05 0.0001138
520 REPRODUCTION 246 1297 1.273e-05 0.0001139
521 REGULATION OF BINDING 69 283 1.304e-05 0.0001164
522 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 34 110 1.332e-05 0.0001187
523 MEMBRANE ASSEMBLY 13 25 1.422e-05 0.0001262
524 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 13 25 1.422e-05 0.0001262
525 LYMPHOCYTE ACTIVATION 80 342 1.441e-05 0.0001271
526 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 26 75 1.443e-05 0.0001271
527 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 17 39 1.44e-05 0.0001271
528 NEURAL CREST CELL DIFFERENTIATION 26 75 1.443e-05 0.0001271
529 CELLULAR RESPONSE TO ALCOHOL 35 115 1.456e-05 0.0001281
530 PEPTIDYL SERINE MODIFICATION 42 148 1.486e-05 0.0001305
531 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 127 602 1.51e-05 0.0001323
532 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 15 32 1.578e-05 0.000138
533 TISSUE MIGRATION 28 84 1.595e-05 0.0001392
534 NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 18 43 1.601e-05 0.0001395
535 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 12 22 1.621e-05 0.000141
536 RESPONSE TO ORGANOPHOSPHORUS 40 139 1.641e-05 0.0001425
537 NEPHRON EPITHELIUM DEVELOPMENT 30 93 1.673e-05 0.0001448
538 POSITIVE REGULATION OF ACTIN NUCLEATION 10 16 1.674e-05 0.0001448
539 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 84 365 1.702e-05 0.0001469
540 CARDIAC CHAMBER DEVELOPMENT 41 144 1.713e-05 0.0001471
541 REGULATION OF JAK STAT CASCADE 41 144 1.713e-05 0.0001471
542 REGULATION OF STAT CASCADE 41 144 1.713e-05 0.0001471
543 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 11 19 1.733e-05 0.0001482
544 GLOMERULAR EPITHELIUM DEVELOPMENT 11 19 1.733e-05 0.0001482
545 VASCULOGENESIS 22 59 1.752e-05 0.0001496
546 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 111 514 1.795e-05 0.000153
547 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 141 684 1.799e-05 0.0001531
548 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 36 121 1.927e-05 0.0001633
549 REGULATION OF PROTEIN KINASE B SIGNALING 36 121 1.927e-05 0.0001633
550 REGULATION OF BLOOD PRESSURE 46 169 1.956e-05 0.0001654
551 CARDIAC MUSCLE CELL CONTRACTION 14 29 1.993e-05 0.000168
552 REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 14 29 1.993e-05 0.000168
553 REGULATION OF AMINE TRANSPORT 25 72 2.03e-05 0.0001708
554 NEGATIVE REGULATION OF MAPK CASCADE 41 145 2.051e-05 0.0001721
555 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 37 126 2.052e-05 0.0001721
556 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 27 81 2.246e-05 0.0001879
557 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 33 108 2.308e-05 0.0001928
558 NEGATIVE REGULATION OF SECRETION 52 200 2.339e-05 0.0001951
559 PROTEIN DEPHOSPHORYLATION 50 190 2.354e-05 0.0001959
560 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 31 99 2.366e-05 0.0001966
561 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 19 48 2.435e-05 0.000202
562 NEGATIVE REGULATION OF ION TRANSPORT 37 127 2.488e-05 0.000206
563 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 43 156 2.583e-05 0.0002134
564 CARDIAC CHAMBER MORPHOGENESIS 32 104 2.612e-05 0.0002147
565 POSITIVE REGULATION OF PROTEIN IMPORT 32 104 2.612e-05 0.0002147
566 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 32 104 2.612e-05 0.0002147
567 POSITIVE REGULATION OF STAT CASCADE 25 73 2.657e-05 0.0002173
568 POSITIVE REGULATION OF PROTEIN SECRETION 54 211 2.657e-05 0.0002173
569 POSITIVE REGULATION OF JAK STAT CASCADE 25 73 2.657e-05 0.0002173
570 SYNAPTIC SIGNALING 94 424 2.681e-05 0.0002189
571 INTEGRIN MEDIATED SIGNALING PATHWAY 27 82 2.881e-05 0.0002347
572 EMBRYONIC ORGAN MORPHOGENESIS 67 279 2.896e-05 0.0002351
573 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 16 37 2.9e-05 0.0002351
574 AXON EXTENSION 16 37 2.9e-05 0.0002351
575 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 38 133 3.145e-05 0.0002545
576 CELL SUBSTRATE JUNCTION ASSEMBLY 17 41 3.185e-05 0.0002573
577 POSITIVE REGULATION OF STEM CELL PROLIFERATION 22 61 3.209e-05 0.0002588
578 MEMBRANE BIOGENESIS 14 30 3.229e-05 0.0002591
579 NEGATIVE REGULATION OF CELL MATRIX ADHESION 14 30 3.229e-05 0.0002591
580 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 14 30 3.229e-05 0.0002591
581 CAMP CATABOLIC PROCESS 9 14 3.299e-05 0.0002642
582 PARTURITION 11 20 3.335e-05 0.0002662
583 AXONAL FASCICULATION 11 20 3.335e-05 0.0002662
584 SKELETAL MUSCLE CELL DIFFERENTIATION 20 53 3.417e-05 0.0002722
585 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 10 17 3.525e-05 0.0002804
586 NEGATIVE REGULATION OF CELL CYCLE 95 433 3.728e-05 0.000296
587 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 15 34 3.861e-05 0.000305
588 FOREBRAIN NEURON DEVELOPMENT 15 34 3.861e-05 0.000305
589 RESPONSE TO FLUID SHEAR STRESS 15 34 3.861e-05 0.000305
590 REGULATION OF VASOCONSTRICTION 23 66 4.025e-05 0.0003174
591 SEX DIFFERENTIATION 64 266 4.061e-05 0.0003197
592 REGULATION OF CATENIN IMPORT INTO NUCLEUS 13 27 4.099e-05 0.0003217
593 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 13 27 4.099e-05 0.0003217
594 REGULATION OF VESICLE MEDIATED TRANSPORT 100 462 4.162e-05 0.000326
595 REGULATION OF STEM CELL PROLIFERATION 28 88 4.176e-05 0.0003266
596 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 22 62 4.285e-05 0.0003345
597 REGULATION OF RENAL SYSTEM PROCESS 16 38 4.324e-05 0.0003365
598 ACTIN FILAMENT ORGANIZATION 46 174 4.325e-05 0.0003365
599 REGULATION OF CELL CELL ADHESION 85 380 4.56e-05 0.0003542
600 REGULATION OF CELL CYCLE 184 949 4.65e-05 0.0003606
601 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 19 50 4.769e-05 0.0003692
602 NEGATIVE REGULATION OF IMMUNE RESPONSE 35 121 4.795e-05 0.0003707
603 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 24 71 4.869e-05 0.0003757
604 PLATELET DEGRANULATION 32 107 4.879e-05 0.0003758
605 PHAGOCYTOSIS 49 190 4.962e-05 0.0003816
606 ENDOCYTOSIS 108 509 5e-05 0.0003839
607 OSTEOBLAST DIFFERENTIATION 36 126 5.017e-05 0.0003845
608 HOMEOSTASIS OF NUMBER OF CELLS 46 175 5.038e-05 0.0003856
609 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 24 5.076e-05 0.0003878
610 ADULT LOCOMOTORY BEHAVIOR 26 80 5.174e-05 0.0003947
611 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 54 216 5.295e-05 0.0004032
612 ENDOMEMBRANE SYSTEM ORGANIZATION 100 465 5.431e-05 0.0004129
613 REGULATION OF RECEPTOR ACTIVITY 34 117 5.511e-05 0.0004183
614 REGULATION OF CALCIUM ION IMPORT 31 103 5.56e-05 0.0004213
615 SKELETAL SYSTEM MORPHOGENESIS 51 201 5.583e-05 0.0004224
616 CELL FATE COMMITMENT 56 227 5.777e-05 0.0004364
617 HEART PROCESS 27 85 5.874e-05 0.000443
618 LIPID LOCALIZATION 63 264 6.017e-05 0.0004531
619 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 21 59 6.032e-05 0.0004535
620 REGULATION OF HOMOTYPIC CELL CELL ADHESION 71 307 6.248e-05 0.0004682
621 REGULATION OF PROTEIN TARGETING 71 307 6.248e-05 0.0004682
622 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 16 39 6.33e-05 0.0004732
623 CRANIAL SKELETAL SYSTEM DEVELOPMENT 20 55 6.336e-05 0.0004732
624 NEURAL CREST CELL MIGRATION 19 51 6.553e-05 0.0004875
625 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 19 51 6.553e-05 0.0004875
626 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 26 81 6.559e-05 0.0004875
627 MUSCLE HYPERTROPHY 13 28 6.618e-05 0.0004903
628 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 13 28 6.618e-05 0.0004903
629 NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 18 47 6.651e-05 0.000492
630 POSITIVE REGULATION OF RESPONSE TO WOUNDING 43 162 6.826e-05 0.0005042
631 OVULATION 10 18 6.877e-05 0.0005063
632 ORGAN GROWTH 23 68 6.87e-05 0.0005063
633 CATION TRANSPORT 157 796 6.93e-05 0.0005094
634 SENSORY ORGAN MORPHOGENESIS 58 239 7.055e-05 0.0005178
635 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 9 15 7.161e-05 0.0005231
636 REGULATION OF HEAT GENERATION 9 15 7.161e-05 0.0005231
637 NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 9 15 7.161e-05 0.0005231
638 REGULATION OF SODIUM ION TRANSPORT 25 77 7.292e-05 0.000531
639 ACTOMYOSIN STRUCTURE ORGANIZATION 25 77 7.292e-05 0.000531
640 NEGATIVE REGULATION OF CELL CELL ADHESION 38 138 7.583e-05 0.0005513
641 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 30 100 7.771e-05 0.0005641
642 NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT 14 32 7.82e-05 0.0005668
643 HORMONE MEDIATED SIGNALING PATHWAY 42 158 7.948e-05 0.0005742
644 NEGATIVE REGULATION OF CELL ACTIVATION 42 158 7.948e-05 0.0005742
645 REGULATION OF GLUCOSE IMPORT 21 60 7.998e-05 0.000577
646 LYMPHOCYTE DIFFERENTIATION 52 209 8.239e-05 0.0005934
647 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 12 25 8.45e-05 0.0006077
648 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 36 129 8.577e-05 0.0006159
649 POSITIVE REGULATION OF AXON EXTENSION 15 36 8.643e-05 0.0006178
650 NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 15 36 8.643e-05 0.0006178
651 POSITIVE CHEMOTAXIS 15 36 8.643e-05 0.0006178
652 MYELOID LEUKOCYTE DIFFERENTIATION 29 96 8.852e-05 0.0006317
653 POSITIVE REGULATION OF AXONOGENESIS 23 69 8.875e-05 0.0006324
654 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 16 40 9.109e-05 0.0006461
655 FORELIMB MORPHOGENESIS 16 40 9.109e-05 0.0006461
656 NEGATIVE REGULATION OF DEFENSE RESPONSE 39 144 9.101e-05 0.0006461
657 REGULATION OF MYOBLAST DIFFERENTIATION 18 48 9.18e-05 0.0006501
658 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 33 115 9.231e-05 0.0006518
659 RESPONSE TO INTERLEUKIN 1 33 115 9.231e-05 0.0006518
660 CELL CYCLE ARREST 41 154 9.253e-05 0.0006524
661 POSITIVE REGULATION OF MUSCLE CONTRACTION 17 44 9.268e-05 0.0006524
662 REGULATION OF EXTENT OF CELL GROWTH 30 101 9.509e-05 0.0006684
663 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 22 65 9.698e-05 0.0006806
664 STEROID HORMONE MEDIATED SIGNALING PATHWAY 35 125 9.929e-05 0.0006957
665 IMMUNE RESPONSE 207 1100 0.0001009 0.0007059
666 ACTIN MEDIATED CELL CONTRACTION 24 74 0.0001028 0.0007184
667 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 13 29 0.0001038 0.0007227
668 CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 13 29 0.0001038 0.0007227
669 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 37 135 0.0001041 0.0007241
670 NEGATIVE REGULATION OF MUSCLE CONTRACTION 11 22 0.0001051 0.0007291
671 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 21 61 0.0001051 0.0007291
672 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 32 111 0.0001063 0.0007361
673 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 52 211 0.0001071 0.0007404
674 SENSORY PERCEPTION OF MECHANICAL STIMULUS 41 155 0.0001081 0.0007462
675 METAL ION TRANSPORT 119 582 0.000113 0.0007775
676 ENDOTHELIAL CELL MIGRATION 20 57 0.0001128 0.0007775
677 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 30 102 0.0001159 0.0007965
678 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 25 79 0.0001164 0.0007976
679 REGULATION OF STRIATED MUSCLE CONTRACTION 25 79 0.0001164 0.0007976
680 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 14 33 0.0001174 0.0008022
681 REGULATION OF CELL AGING 14 33 0.0001174 0.0008022
682 NEURON PROJECTION EXTENSION 19 53 0.0001197 0.0008156
683 CELLULAR RESPONSE TO AMINO ACID STIMULUS 19 53 0.0001197 0.0008156
684 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 56 233 0.0001227 0.0008344
685 CYTOKINE MEDIATED SIGNALING PATHWAY 96 452 0.0001229 0.0008347
686 CORONARY VASCULATURE DEVELOPMENT 15 37 0.0001256 0.0008506
687 HINDLIMB MORPHOGENESIS 15 37 0.0001256 0.0008506
688 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 10 19 0.0001259 0.0008517
689 EXOCRINE SYSTEM DEVELOPMENT 17 45 0.0001286 0.0008682
690 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 26 84 0.0001292 0.0008686
691 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 26 84 0.0001292 0.0008686
692 AORTA DEVELOPMENT 16 41 0.000129 0.0008686
693 CALCIUM ION TRANSPORT 54 223 0.0001306 0.0008766
694 LEUKOCYTE CHEMOTAXIS 33 117 0.0001329 0.0008895
695 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 29 98 0.0001328 0.0008895
696 REGULATION OF CELLULAR SENESCENCE 12 26 0.0001359 0.0009082
697 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 16 0.0001422 0.0009463
698 NEURON CELL CELL ADHESION 9 16 0.0001422 0.0009463
699 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 9 16 0.0001422 0.0009463
700 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 83 381 0.0001437 0.0009552
701 REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS 8 13 0.0001451 0.0009633
702 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 39 147 0.0001467 0.0009719
703 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 40 152 0.0001468 0.0009719
704 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 47 188 0.0001562 0.001032
705 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 13 30 0.0001584 0.001038
706 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 13 30 0.0001584 0.001038
707 BROWN FAT CELL DIFFERENTIATION 13 30 0.0001584 0.001038
708 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 13 30 0.0001584 0.001038
709 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 13 30 0.0001584 0.001038
710 REGULATION OF MEMBRANE REPOLARIZATION 13 30 0.0001584 0.001038
711 PALATE DEVELOPMENT 26 85 0.0001602 0.001049
712 LIPID PHOSPHORYLATION 29 99 0.0001615 0.001056
713 T CELL DIFFERENTIATION 34 123 0.0001627 0.001062
714 EXTRACELLULAR MATRIX DISASSEMBLY 24 76 0.0001639 0.001068
715 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 35 128 0.000166 0.001078
716 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 50 204 0.0001659 0.001078
717 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 18 50 0.0001688 0.001094
718 VASCULAR PROCESS IN CIRCULATORY SYSTEM 42 163 0.0001686 0.001094
719 RESPONSE TO METAL ION 74 333 0.0001697 0.001098
720 RESPONSE TO CAMP 30 104 0.0001701 0.001099
721 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 38 143 0.0001709 0.001103
722 POSITIVE REGULATION OF SODIUM ION TRANSPORT 14 34 0.0001726 0.001111
723 RENAL WATER HOMEOSTASIS 14 34 0.0001726 0.001111
724 MESONEPHROS DEVELOPMENT 27 90 0.0001734 0.001115
725 REGULATION OF METANEPHROS DEVELOPMENT 11 23 0.0001746 0.001119
726 DIVALENT INORGANIC CATION TRANSPORT 62 268 0.0001746 0.001119
727 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 17 46 0.000176 0.001127
728 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 31 109 0.0001774 0.001132
729 RESPONSE TO HYDROGEN PEROXIDE 31 109 0.0001774 0.001132
730 BONE MINERALIZATION 15 38 0.0001793 0.00114
731 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 15 38 0.0001793 0.00114
732 REGULATION OF ACTION POTENTIAL 15 38 0.0001793 0.00114
733 DENDRITE MORPHOGENESIS 16 42 0.00018 0.001142
734 METANEPHROS DEVELOPMENT 25 81 0.0001816 0.001149
735 PEPTIDYL AMINO ACID MODIFICATION 162 841 0.0001815 0.001149
736 REGULATION OF ORGANELLE ORGANIZATION 218 1178 0.0001829 0.001156
737 REGULATION OF EMBRYONIC DEVELOPMENT 32 114 0.0001836 0.001159
738 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 28 95 0.0001853 0.001168
739 RESPONSE TO EXTRACELLULAR STIMULUS 93 441 0.000202 0.001272
740 REGULATION OF NEUROTRANSMITTER LEVELS 47 190 0.0002038 0.001281
741 ODONTOGENESIS 30 105 0.0002049 0.001286
742 REGULATION OF KIDNEY DEVELOPMENT 19 55 0.00021 0.001315
743 REGULATION OF B CELL PROLIFERATION 19 55 0.00021 0.001315
744 FORMATION OF PRIMARY GERM LAYER 31 110 0.0002125 0.001326
745 ENSHEATHMENT OF NEURONS 27 91 0.0002123 0.001326
746 AXON ENSHEATHMENT 27 91 0.0002123 0.001326
747 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 10 20 0.0002185 0.001361
748 NEGATIVE REGULATION OF CELL GROWTH 43 170 0.000221 0.001375
749 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 18 51 0.0002251 0.001397
750 RESPONSE TO NICOTINE 18 51 0.0002251 0.001397
751 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 23 73 0.0002311 0.00143
752 CELLULAR RESPONSE TO KETONE 23 73 0.0002311 0.00143
753 INFLAMMATORY RESPONSE 95 454 0.0002314 0.00143
754 MEMBRANE ORGANIZATION 171 899 0.0002331 0.001439
755 GLYCOPROTEIN METABOLIC PROCESS 77 353 0.0002347 0.001447
756 ESTABLISHMENT OF PROTEIN LOCALIZATION 257 1423 0.0002469 0.001519
757 CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 16 43 0.0002476 0.001522
758 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 20 60 0.0002506 0.001538
759 REGULATION OF AXON GUIDANCE 15 39 0.0002518 0.001542
760 LONG TERM SYNAPTIC POTENTIATION 15 39 0.0002518 0.001542
761 NEGATIVE REGULATION OF OSSIFICATION 22 69 0.0002592 0.001585
762 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 9 17 0.0002624 0.0016
763 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 9 17 0.0002624 0.0016
764 PROTEIN AUTOPHOSPHORYLATION 47 192 0.000264 0.001608
765 RESPONSE TO ETHANOL 36 136 0.0002713 0.00165
766 PROTEOGLYCAN METABOLIC PROCESS 25 83 0.0002772 0.001684
767 FOCAL ADHESION ASSEMBLY 11 24 0.0002794 0.001689
768 REGULATION OF POSITIVE CHEMOTAXIS 11 24 0.0002794 0.001689
769 POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 11 24 0.0002794 0.001689
770 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 11 24 0.0002794 0.001689
771 CELLULAR RESPONSE TO RETINOIC ACID 21 65 0.0002895 0.001747
772 IN UTERO EMBRYONIC DEVELOPMENT 69 311 0.0002898 0.001747
773 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 7 11 0.0002926 0.001759
774 REGULATION OF FEVER GENERATION 7 11 0.0002926 0.001759
775 RESPONSE TO RETINOIC ACID 30 107 0.0002939 0.001765
776 CRANIOFACIAL SUTURE MORPHOGENESIS 8 14 0.0002946 0.001767
777 REGULATION OF COAGULATION 26 88 0.0002968 0.001775
778 REGULATION OF LIPID CATABOLIC PROCESS 18 52 0.0002971 0.001775
779 REGULATION OF CATION CHANNEL ACTIVITY 26 88 0.0002968 0.001775
780 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 32 117 0.0003078 0.001836
781 POSITIVE REGULATION OF BINDING 34 127 0.0003149 0.001876
782 HINDBRAIN DEVELOPMENT 36 137 0.0003164 0.001882
783 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 17 48 0.0003183 0.001887
784 REGULATION OF LIPID KINASE ACTIVITY 17 48 0.0003183 0.001887
785 POSITIVE REGULATION OF WOUND HEALING 17 48 0.0003183 0.001887
786 NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 12 28 0.0003209 0.0019
787 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 16 44 0.0003361 0.001987
788 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 25 84 0.00034 0.002007
789 ION TRANSMEMBRANE TRANSPORT 157 822 0.0003411 0.002012
790 REGULATION OF IMMUNE RESPONSE 163 858 0.0003437 0.002024
791 ENDODERMAL CELL DIFFERENTIATION 15 40 0.0003482 0.002048
792 MUCOPOLYSACCHARIDE METABOLIC PROCESS 30 108 0.0003502 0.002058
793 REGULATION OF ERYTHROCYTE DIFFERENTIATION 14 36 0.000352 0.002065
794 CIRCADIAN REGULATION OF GENE EXPRESSION 19 57 0.0003548 0.002079
795 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 39 153 0.0003577 0.002093
796 POSITIVE REGULATION OF AUTOPHAGY 23 75 0.0003591 0.002096
797 MULTI ORGANISM BEHAVIOR 23 75 0.0003591 0.002096
798 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 10 21 0.000362 0.002106
799 LIPID TRANSLOCATION 10 21 0.000362 0.002106
800 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 21 0.000362 0.002106
801 FOREBRAIN GENERATION OF NEURONS 21 66 0.0003661 0.002124
802 LENS DEVELOPMENT IN CAMERA TYPE EYE 21 66 0.0003661 0.002124
803 PLACENTA DEVELOPMENT 36 138 0.000368 0.002133
804 MAMMARY GLAND EPITHELIUM DEVELOPMENT 18 53 0.0003884 0.002244
805 REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY 18 53 0.0003884 0.002244
806 CELLULAR RESPONSE TO MECHANICAL STIMULUS 24 80 0.0003888 0.002244
807 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 50 211 0.0003916 0.002258
808 REGULATION OF DEFENSE RESPONSE 146 759 0.0003955 0.002275
809 POSITIVE REGULATION OF CYTOKINE PRODUCTION 79 370 0.000395 0.002275
810 MULTI ORGANISM REPRODUCTIVE PROCESS 168 891 0.0004059 0.002331
811 PROTEIN LOCALIZATION TO MEMBRANE 80 376 0.000408 0.002341
812 CARDIAC VENTRICLE MORPHOGENESIS 20 62 0.0004094 0.002343
813 REGULATION OF TISSUE REMODELING 20 62 0.0004094 0.002343
814 EPHRIN RECEPTOR SIGNALING PATHWAY 25 85 0.0004149 0.002371
815 CARDIAC SEPTUM MORPHOGENESIS 17 49 0.0004209 0.002403
816 NEGATIVE REGULATION OF AMINE TRANSPORT 11 25 0.0004326 0.002467
817 REGULATION OF OXIDOREDUCTASE ACTIVITY 26 90 0.0004372 0.00249
818 POTASSIUM ION HOMEOSTASIS 9 18 0.0004561 0.002585
819 RESPONSE TO CAFFEINE 9 18 0.0004561 0.002585
820 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 27 95 0.000456 0.002585
821 OSTEOBLAST DEVELOPMENT 9 18 0.0004561 0.002585
822 REGULATION OF LIPID STORAGE 15 41 0.0004747 0.002658
823 REGULATION OF MEMBRANE DEPOLARIZATION 15 41 0.0004747 0.002658
824 REGULATION OF HEART MORPHOGENESIS 12 29 0.0004742 0.002658
825 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 12 29 0.0004742 0.002658
826 MULTICELLULAR ORGANISMAL HOMEOSTASIS 61 272 0.0004701 0.002658
827 GLUTAMATE RECEPTOR SIGNALING PATHWAY 15 41 0.0004747 0.002658
828 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 15 41 0.0004747 0.002658
829 PEPTIDYL TYROSINE DEPHOSPHORYLATION 28 100 0.0004713 0.002658
830 LIMBIC SYSTEM DEVELOPMENT 28 100 0.0004713 0.002658
831 LACTATION 15 41 0.0004747 0.002658
832 MATING 14 37 0.0004898 0.002723
833 ACTIN POLYMERIZATION OR DEPOLYMERIZATION 14 37 0.0004898 0.002723
834 REGULATION OF RECEPTOR INTERNALIZATION 14 37 0.0004898 0.002723
835 REGULATION OF MUSCLE HYPERTROPHY 14 37 0.0004898 0.002723
836 GLIAL CELL MIGRATION 14 37 0.0004898 0.002723
837 CAMP MEDIATED SIGNALING 14 37 0.0004898 0.002723
838 RESPONSE TO CORTICOSTEROID 43 176 0.0004913 0.002728
839 PATTERN SPECIFICATION PROCESS 87 418 0.0004955 0.002748
840 RESPONSE TO CALCIUM ION 31 115 0.0004982 0.002759
841 REGULATION OF OSTEOCLAST DIFFERENTIATION 20 63 0.0005175 0.002855
842 AMINOGLYCAN METABOLIC PROCESS 41 166 0.0005179 0.002855
843 REGULATION OF MUSCLE ADAPTATION 20 63 0.0005175 0.002855
844 REGULATION OF CELL KILLING 20 63 0.0005175 0.002855
845 NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 8 15 0.0005495 0.003015
846 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 8 15 0.0005495 0.003015
847 REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 8 15 0.0005495 0.003015
848 MEMBRANE REPOLARIZATION 8 15 0.0005495 0.003015
849 CELLULAR RESPONSE TO CAMP 17 50 0.0005508 0.003015
850 RESPONSE TO PROGESTERONE 17 50 0.0005508 0.003015
851 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 36 141 0.0005709 0.003121
852 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 21 68 0.0005738 0.003126
853 NERVE DEVELOPMENT 21 68 0.0005738 0.003126
854 REGULATION OF PHAGOCYTOSIS 21 68 0.0005738 0.003126
855 AORTA MORPHOGENESIS 10 22 0.0005761 0.003135
856 GLIAL CELL DIFFERENTIATION 35 136 0.0005777 0.00314
857 KIDNEY MORPHOGENESIS 24 82 0.00058 0.003149
858 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 34 131 0.0005829 0.003161
859 POSITIVE REGULATION OF PHAGOCYTOSIS 16 46 0.000597 0.003234
860 REGULATION OF PROTEIN COMPLEX ASSEMBLY 79 375 0.0006032 0.003263
861 NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 7 12 0.0006125 0.003287
862 REGULATION OF BROWN FAT CELL DIFFERENTIATION 7 12 0.0006125 0.003287
863 REGULATION OF FATTY ACID METABOLIC PROCESS 25 87 0.0006091 0.003287
864 CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 7 12 0.0006125 0.003287
865 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 25 87 0.0006091 0.003287
866 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 7 12 0.0006125 0.003287
867 POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 7 12 0.0006125 0.003287
868 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 47 199 0.0006211 0.00333
869 REGULATION OF CATABOLIC PROCESS 140 731 0.0006221 0.003331
870 ASSOCIATIVE LEARNING 22 73 0.0006236 0.003335
871 DEPHOSPHORYLATION 63 286 0.0006314 0.003373
872 POSITIVE REGULATION OF GLUCOSE TRANSPORT 15 42 0.0006384 0.003403
873 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 15 42 0.0006384 0.003403
874 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 18 55 0.0006454 0.003436
875 REGULATION OF AMINO ACID TRANSPORT 11 26 0.0006502 0.003458
876 RENAL TUBULE DEVELOPMENT 23 78 0.0006667 0.003541
877 SMOOTH MUSCLE CELL DIFFERENTIATION 12 30 0.0006848 0.003621
878 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 32 122 0.0006844 0.003621
879 REGULATION OF NEURON MIGRATION 12 30 0.0006848 0.003621
880 LAMELLIPODIUM ASSEMBLY 12 30 0.0006848 0.003621
881 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 34 0.0006887 0.003629
882 REGULATION OF MESENCHYMAL CELL PROLIFERATION 13 34 0.0006887 0.003629
883 HEART VALVE DEVELOPMENT 13 34 0.0006887 0.003629
884 ORGAN REGENERATION 24 83 0.0007031 0.003701
885 REGULATION OF DEPHOSPHORYLATION 39 158 0.0007077 0.003721
886 SYNAPSE ASSEMBLY 21 69 0.0007114 0.003736
887 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 17 51 0.0007137 0.00374
888 NEGATIVE REGULATION OF CHEMOTAXIS 17 51 0.0007137 0.00374
889 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 38 153 0.000725 0.003794
890 REGULATION OF MONOOXYGENASE ACTIVITY 19 60 0.0007321 0.003827
891 RESPONSE TO MUSCLE STRETCH 9 19 0.0007532 0.00392
892 MACROPHAGE DIFFERENTIATION 9 19 0.0007532 0.00392
893 REGULATION OF LONG TERM SYNAPTIC POTENTIATION 9 19 0.0007532 0.00392
894 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 9 19 0.0007532 0.00392
895 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 26 93 0.0007569 0.003922
896 REGULATION OF DNA BINDING 26 93 0.0007569 0.003922
897 MULTICELLULAR ORGANISM METABOLIC PROCESS 26 93 0.0007569 0.003922
898 POSITIVE REGULATION OF BLOOD CIRCULATION 26 93 0.0007569 0.003922
899 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 16 47 0.0007822 0.004044
900 POSITIVE REGULATION OF DEPHOSPHORYLATION 16 47 0.0007822 0.004044
901 REGULATION OF PHOSPHATASE ACTIVITY 33 128 0.0007896 0.004078
902 NEGATIVE REGULATION OF PROTEIN SECRETION 29 108 0.0007959 0.004106
903 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 23 79 0.0008107 0.004178
904 RESPONSE TO STARVATION 38 154 0.0008276 0.00426
905 APOPTOTIC SIGNALING PATHWAY 63 289 0.0008374 0.004306
906 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 15 43 0.0008478 0.004349
907 CELL FATE DETERMINATION 15 43 0.0008478 0.004349
908 GLUCOSE HOMEOSTASIS 41 170 0.0008624 0.00441
909 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 74 351 0.0008613 0.00441
910 CARBOHYDRATE HOMEOSTASIS 41 170 0.0008624 0.00441
911 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 21 70 0.0008766 0.004477
912 RESPONSE TO INCREASED OXYGEN LEVELS 10 23 0.0008849 0.004495
913 REGULATION OF OSTEOBLAST PROLIFERATION 10 23 0.0008849 0.004495
914 RESPONSE TO HYPEROXIA 10 23 0.0008849 0.004495
915 REGULATION OF RESPIRATORY GASEOUS EXCHANGE 10 23 0.0008849 0.004495
916 INNERVATION 10 23 0.0008849 0.004495
917 NEGATIVE CHEMOTAXIS 14 39 0.0009056 0.004595
918 MYELOID LEUKOCYTE MIGRATION 27 99 0.0009178 0.004647
919 OVARIAN FOLLICLE DEVELOPMENT 19 61 0.0009178 0.004647
920 REGULATION OF RESPIRATORY SYSTEM PROCESS 8 16 0.0009569 0.004783
921 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 8 16 0.0009569 0.004783
922 HIPPO SIGNALING 11 27 0.0009517 0.004783
923 BONE REMODELING 13 35 0.0009488 0.004783
924 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 8 16 0.0009569 0.004783
925 RESPONSE TO EPINEPHRINE 8 16 0.0009569 0.004783
926 SUBSTRATE DEPENDENT CELL MIGRATION 11 27 0.0009517 0.004783
927 ORGANELLE LOCALIZATION 85 415 0.0009533 0.004783
928 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 8 16 0.0009569 0.004783
929 POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 11 27 0.0009517 0.004783
930 MONOCYTE DIFFERENTIATION 8 16 0.0009569 0.004783
931 REGULATION OF FATTY ACID BETA OXIDATION 8 16 0.0009569 0.004783
932 ADULT WALKING BEHAVIOR 12 31 0.0009682 0.004818
933 CARDIAC ATRIUM DEVELOPMENT 12 31 0.0009682 0.004818
934 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 12 31 0.0009682 0.004818
935 WALKING BEHAVIOR 12 31 0.0009682 0.004818
936 INSULIN RECEPTOR SIGNALING PATHWAY 23 80 0.000981 0.004877
937 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 36 145 0.0009919 0.004926
938 MYOFIBRIL ASSEMBLY 16 48 0.001014 0.005026
939 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 16 48 0.001014 0.005026
940 CARDIAC SEPTUM DEVELOPMENT 24 85 0.001019 0.005038
941 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 24 85 0.001019 0.005038
942 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 34 135 0.001035 0.005111
943 SYNAPTIC VESICLE CYCLE 25 90 0.001048 0.00516
944 ENDOTHELIUM DEVELOPMENT 25 90 0.001048 0.00516
945 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 25 90 0.001048 0.00516
946 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 45 193 0.001063 0.005229
947 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 26 95 0.001069 0.005253
948 REGULATION OF ACTIN FILAMENT LENGTH 38 156 0.001072 0.005254
949 SKIN EPIDERMIS DEVELOPMENT 21 71 0.001074 0.005254
950 ADHERENS JUNCTION ORGANIZATION 21 71 0.001074 0.005254
951 PROTEIN LOCALIZATION TO NUCLEUS 38 156 0.001072 0.005254
952 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 41 172 0.001101 0.00538
953 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 15 44 0.001112 0.005432
954 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 75 360 0.00113 0.005513
955 REGULATION OF CALCIUM MEDIATED SIGNALING 22 76 0.001133 0.005516
956 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 36 146 0.001132 0.005516
957 RELAXATION OF CARDIAC MUSCLE 7 13 0.001158 0.005588
958 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 7 13 0.001158 0.005588
959 REGULATION OF PHAGOCYTOSIS ENGULFMENT 7 13 0.001158 0.005588
960 EYELID DEVELOPMENT IN CAMERA TYPE EYE 7 13 0.001158 0.005588
961 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 7 13 0.001158 0.005588
962 SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE 7 13 0.001158 0.005588
963 REGULATION OF MEMBRANE INVAGINATION 7 13 0.001158 0.005588
964 EXTRACELLULAR FIBRIL ORGANIZATION 7 13 0.001158 0.005588
965 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 17 53 0.001165 0.005601
966 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 17 53 0.001165 0.005601
967 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 17 53 0.001165 0.005601
968 MESONEPHRIC TUBULE MORPHOGENESIS 17 53 0.001165 0.005601
969 REGULATION OF FIBROBLAST PROLIFERATION 23 81 0.001181 0.005672
970 REFLEX 9 20 0.001191 0.005694
971 RESPONSE TO PROTOZOAN 9 20 0.001191 0.005694
972 RELAXATION OF MUSCLE 9 20 0.001191 0.005694
973 MELANOCYTE DIFFERENTIATION 9 20 0.001191 0.005694
974 POSITIVE REGULATION OF CELL MATRIX ADHESION 14 40 0.001206 0.005754
975 REGULATION OF FILOPODIUM ASSEMBLY 14 40 0.001206 0.005754
976 CELL MATURATION 33 131 0.001211 0.005773
977 POSITIVE REGULATION OF DNA REPLICATION 24 86 0.001218 0.005802
978 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 61 282 0.001224 0.005822
979 SYNAPTIC VESICLE LOCALIZATION 28 106 0.001276 0.006059
980 CARDIAC VENTRICLE DEVELOPMENT 28 106 0.001276 0.006059
981 LAMELLIPODIUM ORGANIZATION 13 36 0.001286 0.006088
982 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 40 168 0.001286 0.006088
983 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 13 36 0.001286 0.006088
984 POSITIVE REGULATION OF CELL ACTIVATION 66 311 0.001332 0.006298
985 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 12 32 0.001343 0.006323
986 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 12 32 0.001343 0.006323
987 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 12 32 0.001343 0.006323
988 ADIPOSE TISSUE DEVELOPMENT 12 32 0.001343 0.006323
989 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 11 28 0.00136 0.006398
990 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 22 77 0.001369 0.006432
991 NEUROEPITHELIAL CELL DIFFERENTIATION 19 63 0.001412 0.006631
992 POSITIVE REGULATION OF RECEPTOR ACTIVITY 15 45 0.001443 0.00675
993 SMOOTH MUSCLE CONTRACTION 15 45 0.001443 0.00675
994 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 15 45 0.001443 0.00675
995 ENDOCHONDRAL BONE MORPHOGENESIS 15 45 0.001443 0.00675
996 POSITIVE REGULATION OF DNA METABOLIC PROCESS 43 185 0.001445 0.006751
997 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 111 573 0.001455 0.00679
998 CELLULAR RESPONSE TO STARVATION 30 117 0.001463 0.006822
999 RESPONSE TO TRANSITION METAL NANOPARTICLE 36 148 0.001467 0.006831
1000 ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 20 68 0.001507 0.007013
1001 ORGANIC ANION TRANSPORT 79 387 0.001554 0.007223
1002 REGULATION OF PROTEIN KINASE A SIGNALING 8 17 0.001574 0.007267
1003 POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 8 17 0.001574 0.007267
1004 NEGATIVE REGULATION OF LIPID STORAGE 8 17 0.001574 0.007267
1005 MAMMARY GLAND ALVEOLUS DEVELOPMENT 8 17 0.001574 0.007267
1006 MAMMARY GLAND LOBULE DEVELOPMENT 8 17 0.001574 0.007267
1007 COPULATION 8 17 0.001574 0.007267
1008 ACTIVATION OF PROTEIN KINASE A ACTIVITY 8 17 0.001574 0.007267
1009 HIPPOCAMPUS DEVELOPMENT 21 73 0.001584 0.007298
1010 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 21 73 0.001584 0.007298
1011 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 18 59 0.001614 0.007427
1012 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 22 78 0.001644 0.00756
1013 REGULATION OF ORGANIC ACID TRANSPORT 16 50 0.001655 0.007581
1014 ENDODERM FORMATION 16 50 0.001655 0.007581
1015 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 45 197 0.001652 0.007581
1016 RHO PROTEIN SIGNAL TRANSDUCTION 16 50 0.001655 0.007581
1017 PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 23 83 0.001689 0.007722
1018 MESODERM DEVELOPMENT 30 118 0.001689 0.007722
1019 NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 13 37 0.001717 0.007827
1020 REGULATION OF MEMBRANE LIPID DISTRIBUTION 13 37 0.001717 0.007827
1021 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 13 37 0.001717 0.007827
1022 CELLULAR RESPONSE TO INTERLEUKIN 1 24 88 0.001719 0.007828
1023 REGULATION OF NEUROTRANSMITTER TRANSPORT 19 64 0.001734 0.007888
1024 REGULATION OF RUFFLE ASSEMBLY 9 21 0.001812 0.008211
1025 REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS 9 21 0.001812 0.008211
1026 BONE RESORPTION 9 21 0.001812 0.008211
1027 NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 9 21 0.001812 0.008211
1028 ORGANIC HYDROXY COMPOUND TRANSPORT 37 155 0.00182 0.008228
1029 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 37 155 0.00182 0.008228
1030 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 12 33 0.001829 0.008263
1031 POSITIVE REGULATION OF CATABOLIC PROCESS 80 395 0.001833 0.008272
1032 NEGATIVE REGULATION OF DNA BINDING 15 46 0.001853 0.008346
1033 PEPTIDYL THREONINE MODIFICATION 15 46 0.001853 0.008346
1034 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 11 29 0.001901 0.008546
1035 EMBRYONIC HINDLIMB MORPHOGENESIS 11 29 0.001901 0.008546
1036 REGULATION OF ACUTE INFLAMMATORY RESPONSE 21 74 0.001909 0.008565
1037 CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 10 25 0.001907 0.008565
1038 POSITIVE REGULATION OF HORMONE SECRETION 30 119 0.001945 0.008719
1039 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 29 114 0.001979 0.008863
1040 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 7 14 0.002021 0.008981
1041 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 7 14 0.002021 0.008981
1042 AMINO ACID BETAINE TRANSPORT 7 14 0.002021 0.008981
1043 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 14 0.002021 0.008981
1044 METANEPHRIC MESENCHYME DEVELOPMENT 7 14 0.002021 0.008981
1045 POSITIVE REGULATION OF CELL SIZE 7 14 0.002021 0.008981
1046 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 7 14 0.002021 0.008981
1047 REGULATION OF SYNAPSE MATURATION 7 14 0.002021 0.008981
1048 EPITHELIAL CELL PROLIFERATION 24 89 0.00203 0.009004
1049 POST EMBRYONIC DEVELOPMENT 24 89 0.00203 0.009004
1050 STRIATED MUSCLE CONTRACTION 26 99 0.002039 0.009035
1051 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 37 156 0.002052 0.009085
1052 LIPID MODIFICATION 47 210 0.002057 0.009093
1053 EPITHELIAL CELL MORPHOGENESIS 14 42 0.002058 0.009093
1054 RESPONSE TO AMMONIUM ION 16 51 0.002086 0.009199
1055 REGULATION OF INTERLEUKIN 12 PRODUCTION 16 51 0.002086 0.009199
1056 LEUKOCYTE CELL CELL ADHESION 55 255 0.002204 0.009712
1057 CELLULAR RESPONSE TO GLUCAGON STIMULUS 13 38 0.002262 0.009946
1058 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 13 38 0.002262 0.009946
NumGOOverlapSizeP ValueAdj. P Value
1 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 286 1199 8.003e-18 7.435e-15
2 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 174 629 1.863e-17 8.652e-15
3 PROTEIN DOMAIN SPECIFIC BINDING 171 624 9.53e-17 2.213e-14
4 MACROMOLECULAR COMPLEX BINDING 319 1399 8.8e-17 2.213e-14
5 REGULATORY REGION NUCLEIC ACID BINDING 209 818 1.531e-16 2.845e-14
6 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 107 328 2.176e-16 3.369e-14
7 CYTOSKELETAL PROTEIN BINDING 206 819 1.504e-15 1.997e-13
8 ENZYME BINDING 371 1737 8.528e-15 9.903e-13
9 PROTEIN COMPLEX BINDING 225 935 1.263e-14 1.303e-12
10 ACTIN BINDING 116 393 3.901e-14 3.624e-12
11 PROTEIN KINASE ACTIVITY 165 640 1.192e-13 1.007e-11
12 RECEPTOR BINDING 319 1476 1.777e-13 1.376e-11
13 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 97 315 2.989e-13 2.136e-11
14 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 77 228 4.736e-13 3.142e-11
15 MOLECULAR FUNCTION REGULATOR 295 1353 5.392e-13 3.339e-11
16 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 75 226 2.553e-12 1.482e-10
17 KINASE ACTIVITY 199 842 2.793e-12 1.526e-10
18 CALCIUM ION BINDING 166 697 1.027e-10 5.302e-09
19 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 88 303 1.184e-10 5.788e-09
20 GLYCOSAMINOGLYCAN BINDING 66 205 2.251e-10 9.959e-09
21 SEQUENCE SPECIFIC DNA BINDING 227 1037 2.18e-10 9.959e-09
22 DOUBLE STRANDED DNA BINDING 177 764 2.57e-10 1.085e-08
23 GROWTH FACTOR BINDING 45 123 1.85e-09 7.47e-08
24 SH3 DOMAIN BINDING 43 116 2.641e-09 1.022e-07
25 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 34 81 2.916e-09 1.084e-07
26 CORE PROMOTER PROXIMAL REGION DNA BINDING 97 371 6.584e-09 2.352e-07
27 KINASE BINDING 142 606 7.275e-09 2.503e-07
28 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 88 329 1.03e-08 3.419e-07
29 PHOSPHOLIPID BINDING 94 360 1.205e-08 3.861e-07
30 IDENTICAL PROTEIN BINDING 248 1209 1.836e-08 5.687e-07
31 LIPID BINDING 149 657 2.997e-08 8.981e-07
32 HEPARIN BINDING 50 157 4.894e-08 1.421e-06
33 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 135 588 6.26e-08 1.762e-06
34 TRANSCRIPTION FACTOR BINDING 123 524 6.647e-08 1.816e-06
35 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 34 90 6.897e-08 1.821e-06
36 CELL ADHESION MOLECULE BINDING 56 186 7.055e-08 1.821e-06
37 ACTIN FILAMENT BINDING 41 121 1.154e-07 2.898e-06
38 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 206 992 1.223e-07 2.989e-06
39 PROTEIN DIMERIZATION ACTIVITY 232 1149 2.042e-07 4.865e-06
40 SULFUR COMPOUND BINDING 64 234 4.309e-07 9.763e-06
41 ENZYME ACTIVATOR ACTIVITY 110 471 4.253e-07 9.763e-06
42 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 26 64 4.501e-07 9.949e-06
43 PROTEIN SERINE THREONINE KINASE ACTIVITY 105 445 4.605e-07 9.949e-06
44 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 50 168 5.111e-07 1.079e-05
45 PROTEIN HOMODIMERIZATION ACTIVITY 155 722 6.078e-07 1.255e-05
46 ION CHANNEL BINDING 37 111 7.449e-07 1.504e-05
47 PROTEIN TYROSINE KINASE ACTIVITY 51 176 9.681e-07 1.911e-05
48 PHOSPHATASE BINDING 48 162 9.873e-07 1.911e-05
49 PHOSPHORIC ESTER HYDROLASE ACTIVITY 89 368 1.134e-06 2.149e-05
50 SIGNAL TRANSDUCER ACTIVITY 325 1731 1.217e-06 2.262e-05
51 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 1.543e-06 2.811e-05
52 PROTEIN PHOSPHATASE BINDING 38 120 2.219e-06 3.965e-05
53 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 28 77 2.348e-06 4.116e-05
54 ENZYME REGULATOR ACTIVITY 193 959 2.791e-06 4.802e-05
55 METALLOPEPTIDASE ACTIVITY 52 188 3.503e-06 5.917e-05
56 INTEGRIN BINDING 34 105 4.291e-06 7.118e-05
57 ZINC ION BINDING 225 1155 4.754e-06 7.748e-05
58 TRANSCRIPTION COREPRESSOR ACTIVITY 58 221 6.001e-06 9.611e-05
59 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 10 15 7.242e-06 0.000114
60 BINDING BRIDGING 48 173 7.449e-06 0.0001153
61 ACTIVATING TRANSCRIPTION FACTOR BINDING 22 57 9.196e-06 0.00014
62 METALLOENDOPEPTIDASE ACTIVITY 35 113 9.509e-06 0.0001425
63 PROTEIN KINASE A BINDING 18 42 1.079e-05 0.0001591
64 PHOSPHATIDYLINOSITOL BINDING 53 200 1.1e-05 0.0001596
65 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 33 105 1.202e-05 0.0001718
66 TRANSITION METAL ION BINDING 263 1400 1.314e-05 0.0001849
67 GROWTH FACTOR RECEPTOR BINDING 38 129 1.476e-05 0.0002046
68 STEROID HORMONE RECEPTOR ACTIVITY 22 59 1.752e-05 0.0002393
69 RIBONUCLEOTIDE BINDING 337 1860 1.961e-05 0.000264
70 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 29 90 2.352e-05 0.0003122
71 RHO GTPASE BINDING 26 78 3.164e-05 0.000414
72 CYTOKINE BINDING 29 92 3.73e-05 0.0004764
73 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 24 70 3.744e-05 0.0004764
74 CALMODULIN BINDING 47 179 4.325e-05 0.000543
75 CHROMATIN BINDING 95 435 4.488e-05 0.000556
76 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 25 76 5.72e-05 0.0006992
77 PROTEIN COMPLEX SCAFFOLD 23 68 6.87e-05 0.0008182
78 RECEPTOR SIGNALING PROTEIN ACTIVITY 45 172 6.826e-05 0.0008182
79 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 37 133 7.407e-05 0.0008602
80 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 27 86 7.368e-05 0.0008602
81 CATION CHANNEL ACTIVITY 69 298 7.569e-05 0.000868
82 PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 46 178 7.869e-05 0.0008915
83 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 99 464 8.104e-05 0.0009071
84 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 12 25 8.45e-05 0.0009345
85 COLLAGEN BINDING 22 65 9.698e-05 0.00106
86 GTPASE BINDING 68 295 9.809e-05 0.00106
87 ACTININ BINDING 13 29 0.0001038 0.001108
88 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 33 116 0.0001109 0.001171
89 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 19 53 0.0001197 0.00125
90 CORE PROMOTER BINDING 40 152 0.0001468 0.001516
91 PROTEIN HETERODIMERIZATION ACTIVITY 98 468 0.000181 0.001848
92 SMAD BINDING 23 72 0.0001837 0.001855
93 VOLTAGE GATED ION CHANNEL ACTIVITY 47 190 0.0002038 0.002035
94 RECEPTOR ACTIVITY 294 1649 0.0002193 0.002167
95 GATED CHANNEL ACTIVITY 72 325 0.0002271 0.0022
96 GROWTH FACTOR ACTIVITY 41 160 0.0002273 0.0022
97 TRANSCRIPTION COFACTOR BINDING 11 24 0.0002794 0.002676
98 HORMONE BINDING 21 65 0.0002895 0.002717
99 SIGNALING ADAPTOR ACTIVITY 23 74 0.0002889 0.002717
100 TRANSCRIPTION COACTIVATOR BINDING 7 11 0.0002926 0.002719
101 ENHANCER BINDING 27 93 0.0003138 0.002886
102 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 17 48 0.0003183 0.002895
103 FIBRONECTIN BINDING 12 28 0.0003209 0.002895
104 BETA CATENIN BINDING 25 84 0.00034 0.003037
105 RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING 14 36 0.000352 0.003085
106 RNA POLYMERASE II TRANSCRIPTION COACTIVATOR ACTIVITY 14 36 0.000352 0.003085
107 G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING 10 21 0.000362 0.003114
108 CYTOKINE RECEPTOR ACTIVITY 26 89 0.000361 0.003114
109 PDZ DOMAIN BINDING 26 90 0.0004372 0.003727
110 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 87 417 0.0004575 0.003864
111 PHOSPHATIDYLSERINE BINDING 13 33 0.0004914 0.004113
112 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 28 101 0.0005614 0.004656
113 CYCLASE ACTIVITY 10 22 0.0005761 0.004736
114 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 11 26 0.0006502 0.005299
115 EXTRACELLULAR MATRIX BINDING 17 51 0.0007137 0.005766
116 PROLINE RICH REGION BINDING 9 19 0.0007532 0.006032
117 PROTEIN TYROSINE PHOSPHATASE ACTIVITY 28 103 0.0007878 0.006256
118 DRUG BINDING 29 109 0.0009337 0.007289
119 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 28 104 0.0009284 0.007289
120 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 8 16 0.0009569 0.007408
121 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING 12 31 0.0009682 0.007433
122 ADENYL NUCLEOTIDE BINDING 266 1514 0.001069 0.008142
123 CHANNEL REGULATOR ACTIVITY 33 131 0.001211 0.009147
124 PEPTIDE HORMONE BINDING 13 36 0.001286 0.009635
125 INSULIN RECEPTOR BINDING 12 32 0.001343 0.009978
NumGOOverlapSizeP ValueAdj. P Value
1 NEURON PROJECTION 267 942 3.776e-28 2.205e-25
2 NEURON PART 325 1265 7.541e-26 2.202e-23
3 INTRINSIC COMPONENT OF PLASMA MEMBRANE 397 1649 1.549e-25 3.016e-23
4 CELL JUNCTION 294 1151 5.684e-23 8.298e-21
5 SYNAPSE 212 754 5.433e-22 6.346e-20
6 MEMBRANE REGION 287 1134 8.613e-22 8.384e-20
7 CELL PROJECTION 403 1786 2.61e-20 2.177e-18
8 POSTSYNAPSE 122 378 4.357e-18 3.181e-16
9 SOMATODENDRITIC COMPARTMENT 178 650 2.352e-17 1.526e-15
10 PLASMA MEMBRANE REGION 233 929 2.62e-17 1.53e-15
11 SYNAPSE PART 169 610 4.693e-17 2.492e-15
12 CELL SURFACE 193 757 2.969e-15 1.418e-13
13 ANCHORING JUNCTION 139 489 3.3e-15 1.418e-13
14 DENDRITE 131 451 3.4e-15 1.418e-13
15 EXTRACELLULAR MATRIX 123 426 3.861e-14 1.503e-12
16 ACTIN CYTOSKELETON 125 444 1.773e-13 6.472e-12
17 CELL LEADING EDGE 105 350 2.037e-13 6.997e-12
18 CELL SUBSTRATE JUNCTION 114 398 5.989e-13 1.943e-11
19 PROTEINACEOUS EXTRACELLULAR MATRIX 104 356 1.655e-12 5.087e-11
20 CELL BODY 132 494 2.398e-12 7.003e-11
21 EXCITATORY SYNAPSE 68 197 3.451e-12 9.598e-11
22 CELL CORTEX 77 238 5.541e-12 1.471e-10
23 AXON 115 418 8.484e-12 2.154e-10
24 CYTOPLASMIC REGION 84 287 2.04e-10 4.964e-09
25 RECEPTOR COMPLEX 92 327 2.887e-10 6.743e-09
26 PLASMA MEMBRANE PROTEIN COMPLEX 127 510 9.196e-10 2.066e-08
27 FILOPODIUM 38 94 1.275e-09 2.758e-08
28 CELL CORTEX PART 44 119 1.901e-09 3.827e-08
29 SYNAPTIC MEMBRANE 76 261 1.889e-09 3.827e-08
30 CELL CELL JUNCTION 101 383 1.969e-09 3.832e-08
31 I BAND 44 121 3.471e-09 6.334e-08
32 PERINUCLEAR REGION OF CYTOPLASM 150 642 3.367e-09 6.334e-08
33 SIDE OF MEMBRANE 109 428 3.818e-09 6.756e-08
34 CELL PROJECTION PART 205 946 4.092e-09 7.029e-08
35 CONTRACTILE FIBER 64 211 6.134e-09 1.024e-07
36 INTRACELLULAR VESICLE 259 1259 6.569e-09 1.066e-07
37 LAMELLIPODIUM 55 172 9.107e-09 1.437e-07
38 ACTOMYOSIN 28 62 1.016e-08 1.521e-07
39 GOLGI APPARATUS 290 1445 1.007e-08 1.521e-07
40 POSTSYNAPTIC MEMBRANE 62 205 1.19e-08 1.737e-07
41 ACTIN FILAMENT 30 70 1.373e-08 1.955e-07
42 MEMBRANE MICRODOMAIN 79 288 1.757e-08 2.443e-07
43 SITE OF POLARIZED GROWTH 49 149 2.107e-08 2.861e-07
44 ACTIN BASED CELL PROJECTION 56 181 2.477e-08 3.288e-07
45 NEURON SPINE 42 121 3.718e-08 4.826e-07
46 APICAL PART OF CELL 90 361 2.4e-07 3.047e-06
47 ENDOCYTIC VESICLE 69 256 2.839e-07 3.528e-06
48 PLATELET ALPHA GRANULE 29 75 3.497e-07 4.169e-06
49 VACUOLE 236 1180 3.498e-07 4.169e-06
50 BASOLATERAL PLASMA MEMBRANE 59 211 5.379e-07 6.283e-06
51 SARCOLEMMA 40 125 8.984e-07 1.029e-05
52 CYTOPLASMIC VESICLE PART 131 601 1.97e-06 2.213e-05
53 CORTICAL CYTOSKELETON 29 81 2.248e-06 2.477e-05
54 ACTIN FILAMENT BUNDLE 23 57 2.361e-06 2.553e-05
55 EXTRACELLULAR MATRIX COMPONENT 39 125 2.476e-06 2.629e-05
56 CORTICAL ACTIN CYTOSKELETON 23 58 3.367e-06 3.511e-05
57 CYTOPLASMIC SIDE OF MEMBRANE 48 170 4.415e-06 4.523e-05
58 PLATELET ALPHA GRANULE LUMEN 22 55 4.624e-06 4.656e-05
59 CYTOSKELETON 359 1967 5.174e-06 5.122e-05
60 T TUBULE 19 45 8.034e-06 7.819e-05
61 ENDOSOME 160 793 1.718e-05 0.0001645
62 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 31 98 1.891e-05 0.0001781
63 AXON PART 56 219 1.954e-05 0.0001812
64 RUFFLE 43 156 2.583e-05 0.0002344
65 PLASMA MEMBRANE RAFT 28 86 2.609e-05 0.0002344
66 APICAL JUNCTION COMPLEX 37 128 3.007e-05 0.0002661
67 APICAL PLASMA MEMBRANE 69 292 3.853e-05 0.0003358
68 PLASMA MEMBRANE RECEPTOR COMPLEX 46 175 5.038e-05 0.0004327
69 SECRETORY GRANULE LUMEN 27 85 5.874e-05 0.0004972
70 ANCHORED COMPONENT OF MEMBRANE 41 152 6.735e-05 0.0005619
71 PHAGOCYTIC VESICLE 27 86 7.368e-05 0.0006061
72 GOLGI APPARATUS PART 173 893 8.154e-05 0.0006614
73 EXTERNAL SIDE OF PLASMA MEMBRANE 57 238 0.0001187 0.0009498
74 DENDRITIC SHAFT 15 37 0.0001256 0.0009911
75 ENDOPLASMIC RETICULUM 292 1631 0.0001729 0.001346
76 EXTRINSIC COMPONENT OF MEMBRANE 59 252 0.0001762 0.001354
77 LEADING EDGE MEMBRANE 36 134 0.0001979 0.001501
78 ENDOPLASMIC RETICULUM LUMEN 49 201 0.0002199 0.001626
79 FILAMENTOUS ACTIN 10 20 0.0002185 0.001626
80 BASAL PART OF CELL 18 51 0.0002251 0.001643
81 VESICLE MEMBRANE 105 512 0.0002476 0.001785
82 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 36 136 0.0002713 0.001932
83 VACUOLAR PART 136 694 0.0002764 0.001945
84 ENDOCYTIC VESICLE MEMBRANE 39 152 0.00031 0.002156
85 SECRETORY GRANULE 76 352 0.0003555 0.002443
86 COATED PIT 21 67 0.0004598 0.003087
87 MAIN AXON 19 58 0.0004553 0.003087
88 PRESYNAPSE 63 283 0.0004719 0.003132
89 GOLGI MEMBRANE 136 703 0.0004837 0.003174
90 VESICLE LUMEN 29 106 0.0005726 0.003716
91 CLATHRIN COATED VESICLE 39 157 0.00062 0.003979
92 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 12 30 0.0006848 0.004347
93 COSTAMERE 9 19 0.0007532 0.00473
94 PODOSOME 10 23 0.0008849 0.005497
95 NEURON PROJECTION TERMINUS 33 129 0.0009129 0.005612
96 MICROVILLUS 22 75 0.0009337 0.00568
97 LYTIC VACUOLE 104 526 0.001006 0.006054
98 EXTRACELLULAR SPACE 244 1376 0.001028 0.006126
99 CATION CHANNEL COMPLEX 40 167 0.001139 0.006722
100 CLATHRIN COATED VESICLE MEMBRANE 23 81 0.001181 0.006898
101 SECRETORY VESICLE 92 461 0.001418 0.008196
102 COATED VESICLE 52 234 0.001458 0.00835
103 BASEMENT MEMBRANE 25 93 0.001737 0.009851

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 PI3K_Akt_signaling_pathway_hsa04151 110 352 2.471e-15 8.026e-14
2 MAPK_signaling_pathway_hsa04010 97 295 3.131e-15 8.026e-14
3 Focal_adhesion_hsa04510 74 199 4.63e-15 8.026e-14
4 cGMP_PKG_signaling_pathway_hsa04022 59 163 9.886e-12 1.131e-10
5 Ras_signaling_pathway_hsa04014 75 232 1.087e-11 1.131e-10
6 Rap1_signaling_pathway_hsa04015 68 206 3.468e-11 3.006e-10
7 cAMP_signaling_pathway_hsa04024 63 198 9.79e-10 7.272e-09
8 Calcium_signaling_pathway_hsa04020 59 182 1.485e-09 9.655e-09
9 FoxO_signaling_pathway_hsa04068 47 132 2.283e-09 1.319e-08
10 Regulation_of_actin_cytoskeleton_hsa04810 63 208 8.543e-09 4.442e-08
11 Gap_junction_hsa04540 34 88 3.596e-08 1.7e-07
12 Apelin_signaling_pathway_hsa04371 45 137 8.134e-08 3.525e-07
13 Cytokine_cytokine_receptor_interaction_hsa04060 71 270 5.326e-07 2.131e-06
14 Cell_adhesion_molecules_.CAMs._hsa04514 44 145 1.35e-06 5.016e-06
15 Phospholipase_D_signaling_pathway_hsa04072 43 146 4.202e-06 1.457e-05
16 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 41 139 6.676e-06 2.17e-05
17 Tight_junction_hsa04530 46 170 2.302e-05 7.04e-05
18 Hippo_signaling_pathway_hsa04390 41 154 9.253e-05 0.0002673
19 Wnt_signaling_pathway_hsa04310 39 146 0.0001254 0.0003359
20 TGF_beta_signaling_pathway_hsa04350 26 84 0.0001292 0.0003359
21 TNF_signaling_pathway_hsa04668 31 108 0.0001476 0.0003655
22 Cellular_senescence_hsa04218 41 160 0.0002273 0.0005374
23 AMPK_signaling_pathway_hsa04152 33 121 0.0002648 0.0005986
24 Jak_STAT_signaling_pathway_hsa04630 41 162 0.0003016 0.0006534
25 Adherens_junction_hsa04520 22 72 0.0005053 0.001051
26 ECM_receptor_interaction_hsa04512 24 82 0.00058 0.00116
27 Hedgehog_signaling_pathway_hsa04340 16 47 0.0007822 0.001485
28 Sphingolipid_signaling_pathway_hsa04071 31 118 0.0007996 0.001485
29 Phagosome_hsa04145 35 152 0.00444 0.007961
30 Mitophagy_animal_hsa04137 18 65 0.005171 0.008963
31 Apoptosis_hsa04210 32 138 0.00566 0.009495
32 Oocyte_meiosis_hsa04114 29 124 0.00721 0.01172
33 ErbB_signaling_pathway_hsa04012 21 85 0.0109 0.01718
34 HIF_1_signaling_pathway_hsa04066 23 100 0.01877 0.02871
35 Neuroactive_ligand_receptor_interaction_hsa04080 53 278 0.02937 0.04364
36 Phosphatidylinositol_signaling_system_hsa04070 22 99 0.03057 0.04416
37 mTOR_signaling_pathway_hsa04150 30 151 0.05363 0.07456
38 Hippo_signaling_pathway_multiple_species_hsa04392 8 29 0.05449 0.07456
39 NF_kappa_B_signaling_pathway_hsa04064 20 95 0.06203 0.0827
40 p53_signaling_pathway_hsa04115 15 68 0.06952 0.09037
41 Autophagy_animal_hsa04140 25 128 0.08556 0.1084
42 VEGF_signaling_pathway_hsa04370 13 59 0.08754 0.1084
43 Endocytosis_hsa04144 44 244 0.0917 0.1109
44 ABC_transporters_hsa02010 10 45 0.1186 0.1402
45 Cell_cycle_hsa04110 23 124 0.1459 0.1686
46 Necroptosis_hsa04217 27 164 0.3034 0.3429
47 Lysosome_hsa04142 20 123 0.3597 0.3979
48 Apoptosis_multiple_species_hsa04215 5 33 0.5512 0.5971
49 Autophagy_other_hsa04136 4 32 0.7172 0.7539
50 Ferroptosis_hsa04216 5 40 0.7249 0.7539
51 Peroxisome_hsa04146 9 83 0.8825 0.8998
52 Notch_signaling_pathway_hsa04330 4 48 0.9386 0.9386

Quest ID: 524c1808407e99bfb2811747a3d768a9